BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Adam R, De Gramont A, Figueras J, Guthrie A, Kokudo N, Kunstlinger F, Loyer E, Poston G, Rougier P, Rubbia-Brandt L, Sobrero A, Tabernero J, Teh C, Van Cutsem E;  Jean-Nicolas Vauthey of the EGOSLIM (Expert Group on OncoSurgery management of LIver Metastases) group. The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus. Oncologist. 2012;17:1225-1239. [PMID: 22962059 DOI: 10.1634/theoncologist.2012-0121] [Cited by in Crossref: 284] [Cited by in F6Publishing: 305] [Article Influence: 28.4] [Reference Citation Analysis]
Number Citing Articles
1 Innominato PF, Cailliez V, Allard MA, Lopez-Ben S, Ferrero A, Marques H, Hubert C, Giuliante F, Pereira F, Cugat E, Mirza DF, Costa-Maia J, Serrablo A, Lapointe R, Dopazo C, Tralhao J, Kaiser G, Chen JS, Garcia-Borobia F, Regimbeau JM, Skipenko O, Lin JK, Laurent C, Opocher E, Goto Y, Chibaudel B, de Gramont A, Adam R. Impact of Preoperative Chemotherapy Features on Patient Outcomes after Hepatectomy for Initially Unresectable Colorectal Cancer Liver Metastases: A LiverMetSurvey Analysis. Cancers (Basel) 2022;14:4340. [PMID: 36077874 DOI: 10.3390/cancers14174340] [Reference Citation Analysis]
2 Zhang L, Qiao L, Zhang M, Xue Y, Zhang X, Gao X. Comparison of prognosis among patients with colorectal cancer liver metastases treated by surgical resection, radiofrequency ablation and HIFU: A protocol for network meta-analysis. Medicine (Baltimore) 2022;101:e27915. [PMID: 35984150 DOI: 10.1097/MD.0000000000027915] [Reference Citation Analysis]
3 Milana F, Famularo S, Luberto A, Rimassa L, Scorsetti M, Comito T, Pressiani T, Franzese C, Poretti D, Di Tommaso L, Personeni N, Rodari M, Pedicini V, Donadon M, Torzilli G. Multidisciplinary Tumor Board in the Management of Patients with Colorectal Liver Metastases: A Single-Center Review of 847 Patients. Cancers 2022;14:3952. [DOI: 10.3390/cancers14163952] [Reference Citation Analysis]
4 Moretto R, Borelli B, Boraschi P, Roffi N, Donati F, Antoniotti C, Della Pina C, Colombatto P, Balestri R, Signori S, Gigoni R, Guidoccio F, Volterrani D, Masi G, Cremolini C, Urbani L. Impact of baseline gadoxetic acid-enhanced liver magnetic resonance and diffusion-weighted imaging in resectable colorectal liver metastases: A prospective, monocentric study. Surg Oncol 2022;44:101836. [PMID: 35998501 DOI: 10.1016/j.suronc.2022.101836] [Reference Citation Analysis]
5 Yoshino K, Osumi H, Ito H, Yamaguchi K, Shinozaki E. ASO Author Reflections: The Role of CEA Optimizing Perioperative Treatments for Colorectal Cancer with Liver Metastases. Ann Surg Oncol 2022. [PMID: 35933537 DOI: 10.1245/s10434-022-12372-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Dehlke K, Krause L, Tyufekchieva S, Murtha-Lemekhova A, Mayer P, Vlasov A, Klingmüller U, Mueller NS, Hoffmann K. Predicting liver regeneration following major resection. Sci Rep 2022;12:13396. [PMID: 35927556 DOI: 10.1038/s41598-022-16968-9] [Reference Citation Analysis]
7 Nishino H, Turner MA, Amirfakhri S, Hollandsworth HM, Lwin TM, Hosseini M, Framery B, Cailler F, Pèlegrin A, Hoffman RM, Bouvet M. Proof of concept of improved fluorescence-guided surgery of colon cancer liver metastasis using color-coded imaging of a tumor-labeling fluorescent antibody and indocyanine green restricted to the adjacent liver segment. Surgery 2022:S0039-6060(22)00412-3. [PMID: 35927078 DOI: 10.1016/j.surg.2022.05.029] [Reference Citation Analysis]
8 Herman P, Fonseca GM, Coelho FF, Kruger JAP, Makdissi FF, Jeismann VB, Carrilho FJ, D'Albuquerque LAC, Nahas SC. Two decades of liver resection with a multidisciplinary approach in a single institution: What has changed? Analysis of 1409 cases. Clinics (Sao Paulo) 2022;77:100088. [PMID: 35901605 DOI: 10.1016/j.clinsp.2022.100088] [Reference Citation Analysis]
9 Chen FL, Wang YY, Liu W, Xing BC. Prognostic factors in colorectal liver metastases patients with various tumor numbers treated by liver resection: a single-center, retrospective study. World J Surg Oncol 2022;20:237. [PMID: 35854361 DOI: 10.1186/s12957-022-02700-4] [Reference Citation Analysis]
10 Margonis GA, Vauthey J. Precision surgery for colorectal liver metastases: Current knowledge and future perspectives. Annals of Gastroent Surgery. [DOI: 10.1002/ags3.12591] [Reference Citation Analysis]
11 Villard C, Abdelrafee A, Habib M, Ndegwa N, Jorns C, Sparrelid E, Allard M, Adam R. Prediction of survival in patients with colorectal liver metastases- development and validation of a prognostic score model. European Journal of Surgical Oncology 2022. [DOI: 10.1016/j.ejso.2022.06.021] [Reference Citation Analysis]
12 Frühling P, Urdzik J, Isaksson B. Chemotherapy in patients with a solitary colorectal liver metastasis – A nationwide propensity score matched study. European Journal of Surgical Oncology 2022. [DOI: 10.1016/j.ejso.2022.05.020] [Reference Citation Analysis]
13 Mohamad I, Barry A, Dawson L, Hosni A. Stereotactic body radiation therapy for colorectal liver metastases. International Journal of Hyperthermia 2022;39:611-9. [DOI: 10.1080/02656736.2021.1923836] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Mauri G, Vitiello PP, Sogari A, Crisafulli G, Sartore-Bianchi A, Marsoni S, Siena S, Bardelli A. Liquid biopsies to monitor and direct cancer treatment in colorectal cancer. Br J Cancer 2022. [PMID: 35264786 DOI: 10.1038/s41416-022-01769-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
15 Shiraiwa DK, Riera R, Kleinubing DR, Linhares MM; Cochrane Hepato-Biliary Group. Associating liver partition and portal vein ligation for staged hepatectomy procedure versus conventional two-stage hepatectomy for colorectal liver metastasis. Cochrane Database of Systematic Reviews 2022;2022. [DOI: 10.1002/14651858.cd014608] [Reference Citation Analysis]
16 Hedrick TL, Zaydfudim VM. Management of Synchronous Colorectal Cancer Metastases. Surgical Oncology Clinics of North America 2022. [DOI: 10.1016/j.soc.2021.11.007] [Reference Citation Analysis]
17 Samoon Z, Naher SK, Sjoquist KM, Zalcberg J. Chemotherapy in resectable or potentially resectable colon cancer with liver metastases. Expert Opin Pharmacother 2022;:1-10. [PMID: 35196945 DOI: 10.1080/14656566.2022.2043276] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
18 Viganò L, Jayakody Arachchige VS, Fiz F. Is precision medicine for colorectal liver metastases still a utopia? New perspectives by modern biomarkers, radiomics, and artificial intelligence. World J Gastroenterol 2022; 28(6): 608-623 [DOI: 10.3748/wjg.v28.i6.608] [Reference Citation Analysis]
19 Watanabe G, Mise Y, Oba M, Saiura A, Inoue Y, Takahashi Y, Kishi Y, Suyama K, Takayama T, Noie T, Nishioka Y, Akamatsu N, Arita J, Kokudo N, Hasegawa K. A multicenter phase II trial evaluating the efficacy of bevacizumab plus mFOLFOX6 for R0 surgical resection in advanced colorectal liver metastases harboring mutant-type KRAS: NEXTO-mt trial. HPB (Oxford) 2022:S1365-182X(22)00052-1. [PMID: 35216869 DOI: 10.1016/j.hpb.2022.02.001] [Reference Citation Analysis]
20 Omichi K, Inoue Y, Mise Y, Oba A, Ono Y, Sato T, Ito H, Takahashi Y, Saiura A. Hepatectomy with Perioperative Chemotherapy for Multiple Colorectal Liver Metastases is the Available Option for Prolonged Survival. Ann Surg Oncol 2022. [PMID: 35118524 DOI: 10.1245/s10434-022-11345-2] [Reference Citation Analysis]
21 Rashad N, Abdulla M, Farouk M, Elkerm Y, Eid Salem S, Yehia M, Saad AS, Abdel Aziz AH, Refaat G, Awad I, Elnaggar M, Kamal K, Refky B, Abdelkhalek M, Touny A, Kassem L, Shash E, Abdelhay AA, Mahmoud BE, Oualla K, Chraiet N, Awadelkarim H Maki H, Kader YA. Resource Oriented Decision Making for Treatment of Metastatic Colorectal Cancer (mCRC) in a Lower-Middle Income Country: Egyptian Foundation of Medical Sciences (EFMS) Consensus Recommendations 2020. CMAR 2022;Volume 14:821-42. [DOI: 10.2147/cmar.s340030] [Reference Citation Analysis]
22 Garcia-vicién G, Mezheyeuski A, Micke P, Ruiz N, Ruffinelli JC, Mils K, Bañuls M, Molina N, Losa F, Lladó L, Molleví DG. Spatial Immunology in Liver Metastases from Colorectal Carcinoma according to the Histologic Growth Pattern. Cancers 2022;14:689. [DOI: 10.3390/cancers14030689] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
23 Wada Y, Shimada M, Morine Y, Ikemoto T, Saito Y, Baba H, Mori M, Goel A. A transcriptomic signature that predicts cancer recurrence after hepatectomy in patients with colorectal liver metastases. Eur J Cancer 2022;163:66-76. [PMID: 35042069 DOI: 10.1016/j.ejca.2021.12.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
24 Pernot S, Pellerin O, Mineur L, Monterymard C, Smith D, Lapuyade B, Gallois C, Khemissa Akouz F, De Baere T, Tougeron D, Thirot-Bidault A, Audemar F, Simon M, Lecaille C, Louafi S, Lepage C, Ducreux M, Taieb J. Phase III randomized trial comparing systemic versus intra-arterial oxaliplatin, combined with LV5FU2 +/- irinotecan and a targeted therapy, in the first-line treatment of metastatic colorectal cancer restricted to the liver (OSCAR): PRODIGE 49. Dig Liver Dis 2022:S1590-8658(21)00898-7. [PMID: 35027324 DOI: 10.1016/j.dld.2021.12.012] [Reference Citation Analysis]
25 Cassar N, Geoghegan J, Hoti E. Shifting concepts in the management of colorectal liver metastases. Surgeon 2022:S1479-666X(21)00200-6. [PMID: 34998701 DOI: 10.1016/j.surge.2021.12.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Rocca A, Brunese MC, Santone A, Avella P, Bianco P, Scacchi A, Scaglione M, Bellifemine F, Danzi R, Varriano G, Vallone G, Calise F, Brunese L. Early Diagnosis of Liver Metastases from Colorectal Cancer through CT Radiomics and Formal Methods: A Pilot Study. J Clin Med 2021;11:31. [PMID: 35011771 DOI: 10.3390/jcm11010031] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
27 Hu D, Pan Y, Chen G. Colorectal cancer liver metastases: An update of treatment strategy and future perspectives. Surgery in Practice and Science 2021;7:100042. [DOI: 10.1016/j.sipas.2021.100042] [Reference Citation Analysis]
28 Chan KM, Wang YC, Wu TH, Cheng CH, Lee CF, Wu TJ, Chou HS, Lee WC. Comment on "ALPPS Improves Survival Compared With TSH in Patients Affected of CRLM Survival Analysis From the Randomized Controlled Trial LIGRO": Metastatic Tumor Burden in the Future Liver Remnant for Decision-making of Staged Hepatectomy. Ann Surg 2021;274:e749-50. [PMID: 32590542 DOI: 10.1097/SLA.0000000000004017] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Hasselgren K, Røsok BI, Larsen PN, Sparrelid E, Lindell G, Schultz NA, Bjørnbeth BA, Isaksson B, Larsson AL, Rizell M, Björnsson B, Sandström P. Response to the Comment on "ALPPS Improves Survival Compared With TSH in Patients Affected of CRLM: Survival Analysis From the Randomized Controlled Trial LIGRO-Metastatic Tumor Burden in the Future Liver Remnant for Decision-making of Staged Hepatectomy". Ann Surg 2021;274:e750-1. [PMID: 32590545 DOI: 10.1097/SLA.0000000000004014] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
30 Wesdorp NJ, Bolhuis K, Roor J, van Waesberghe JTM, van Dieren S, van Amerongen MJ, Chapelle T, Dejong CHC, Engelbrecht MRW, Gerhards MF, Grunhagen D, van Gulik TM, Hermans JJ, de Jong KP, Klaase JM, Liem MSL, van Lienden KP, Molenaar IQ, Patijn GA, Rijken AM, Ruers TM, Verhoef C, de Wilt JHW, Swijnenburg R, Punt CJA, Huiskens J, Kazemier G. The Prognostic Value of Total Tumor Volume Response Compared With RECIST1.1 in Patients With Initially Unresectable Colorectal Liver Metastases Undergoing Systemic Treatment. Annals of Surgery Open 2021;2:e103. [DOI: 10.1097/as9.0000000000000103] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Torres-Jiménez J, Esteban-Villarrubia J, Ferreiro-Monteagudo R, Carrato A. Local Treatments in the Unresectable Patient with Colorectal Cancer Metastasis: A Review from the Point of View of the Medical Oncologist. Cancers (Basel) 2021;13:5938. [PMID: 34885047 DOI: 10.3390/cancers13235938] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
32 Chan AKC, Mason JM, Baltatzis M, Siriwardena AK; CoSMIC Collaborators. Management of Colorectal Cancer with Synchronous Liver Metastases: An Inception Cohort Study (CoSMIC). Ann Surg Oncol 2021. [PMID: 34716838 DOI: 10.1245/s10434-021-11017-7] [Reference Citation Analysis]
33 Loosen SH, Roderburg C, Alizai PH, Roeth AA, Schmitz SM, Vucur M, Luedde M, Schöler D, Paffenholz P, Tacke F, Trautwein C, Luedde T, Neumann UP, Ulmer TF. Comparative Analysis of Circulating Biomarkers for Patients Undergoing Resection of Colorectal Liver Metastases. Diagnostics (Basel) 2021;11:1999. [PMID: 34829346 DOI: 10.3390/diagnostics11111999] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
34 Bonney GK, Chew CA, Lodge P, Hubbard J, Halazun KJ, Trunecka P, Muiesan P, Mirza DF, Isaac J, Laing RW, Iyer SG, Chee CE, Yong WP, Muthiah MD, Panaro F, Sanabria J, Grothey A, Moodley K, Chau I, Chan ACY, Wang CC, Menon K, Sapisochin G, Hagness M, Dueland S, Line PD, Adam R. Liver transplantation for non-resectable colorectal liver metastases: the International Hepato-Pancreato-Biliary Association consensus guidelines. Lancet Gastroenterol Hepatol 2021;6:933-46. [PMID: 34506756 DOI: 10.1016/S2468-1253(21)00219-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
35 Kawaguchi Y, Kopetz S, Panettieri E, Hwang H, Wang X, Cao HST, Tzeng CD, Chun YS, Aloia TA, Vauthey JN. Improved Survival over Time After Resection of Colorectal Liver Metastases and Clinical Impact of Multigene Alteration Testing in Patients with Metastatic Colorectal Cancer. J Gastrointest Surg 2021. [PMID: 34506029 DOI: 10.1007/s11605-021-05110-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
36 Viganò L, Gentile D, Galvanin J, Corleone P, Costa G, Cimino M, Procopio F, Torzilli G. Very Early Recurrence After Liver Resection for Colorectal Metastases: Incidence, Risk Factors, and Prognostic Impact. J Gastrointest Surg 2021. [PMID: 34508293 DOI: 10.1007/s11605-021-05123-w] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
37 Bolhuis K, Grosheide L, Wesdorp NJ, Komurcu A, Chapelle T, Dejong CHC, Gerhards MF, Grünhagen DJ, van Gulik TM, Huiskens J, De Jong KP, Kazemier G, Klaase JM, Liem MSL, Molenaar IQ, Patijn GA, Rijken AM, Ruers TM, Verhoef C, de Wilt JHW, Punt CJA, Swijnenburg R. Short-Term Outcomes of Secondary Liver Surgery for Initially Unresectable Colorectal Liver Metastases Following Modern Induction Systemic Therapy in the Dutch CAIRO5 Trial. Annals of Surgery Open 2021;2:e081. [DOI: 10.1097/as9.0000000000000081] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
38 Kitano Y, Hayashi H, Matsumoto T, Kinoshita S, Sato H, Shiraishi Y, Nakao Y, Kaida T, Imai K, Yamashita YI, Baba H. Borderline resectable for colorectal liver metastases: Present status and future perspective. World J Gastrointest Surg 2021; 13(8): 756-763 [PMID: 34512899 DOI: 10.4240/wjgs.v13.i8.756] [Reference Citation Analysis]
39 Zhang C, Wang X, Han J, Zhang R, Chen Z, Li Y, Ma X, Zhang G, Fan J, Chen J. Histological tumor response to neoadjuvant chemotherapy correlates to Immunoscore in colorectal cancer liver metastases patients. J Surg Oncol 2021;124:1431-41. [PMID: 34406653 DOI: 10.1002/jso.26651] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
40 Mauri G, Durinikova E, Amatu A, Tosi F, Cassingena A, Rizzetto F, Buzo K, Arcella P, Aquilano MC, Bonoldi E, Marsoni S, Siena S, Bardelli A, Sartore-Bianchi A, Arena S. Empowering Clinical Decision Making in Oligometastatic Colorectal Cancer: The Potential Role of Drug Screening of Patient-Derived Organoids. JCO Precis Oncol 2021;5:PO. [PMID: 34327296 DOI: 10.1200/PO.21.00143] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
41 D'Silva M, Cho JY, Han HS, Yerlan T, Yoon YS, Lee HW, Lee JS, Lee B, Kim M. Management of indeterminate hepatic nodules and evaluation of factors predicting their malignant potential in patients with colorectal cancer. Sci Rep 2021;11:13744. [PMID: 34215816 DOI: 10.1038/s41598-021-93339-w] [Reference Citation Analysis]
42 Akabane M, Shindoh J, Kobayashi Y, Umino R, Kojima K, Okubo S, Hashimoto M, Matoba S, Kuroyanagi H. Significance of preoperative nutritional status as a predictor for short-term and long-term outcomes of patients undergoing surgery for stage IV colorectal cancer. Langenbecks Arch Surg 2021. [PMID: 34196790 DOI: 10.1007/s00423-021-02255-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
43 Rocca A, Cipriani F, Belli G, Berti S, Boggi U, Bottino V, Cillo U, Cescon M, Cimino M, Corcione F, De Carlis L, Degiuli M, De Paolis P, De Rose AM, D'Ugo D, Di Benedetto F, Elmore U, Ercolani G, Ettorre GM, Ferrero A, Filauro M, Giuliante F, Gruttadauria S, Guglielmi A, Izzo F, Jovine E, Laurenzi A, Marchegiani F, Marini P, Massani M, Mazzaferro V, Mineccia M, Minni F, Muratore A, Nicosia S, Pellicci R, Rosati R, Russolillo N, Spinelli A, Spolverato G, Torzilli G, Vennarecci G, Viganò L, Vincenti L, Delrio P, Calise F, Aldrighetti L. The Italian Consensus on minimally invasive simultaneous resections for synchronous liver metastasis and primary colorectal cancer: A Delphi methodology. Updates Surg 2021;73:1247-65. [PMID: 34089501 DOI: 10.1007/s13304-021-01100-9] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
44 Kanter K, Fish M, Mauri G, Horick NK, Allen JN, Blaszkowsky LS, Clark JW, Ryan DP, Nipp RD, Giantonio BJ, Goyal L, Dubois J, Murphy JE, Franses J, Klempner SJ, Roeland EJ, Weekes CD, Wo JY, Hong TS, Van Seventer EE, Corcoran RB, Parikh AR. Care Patterns and Overall Survival in Patients With Early-Onset Metastatic Colorectal Cancer. JCO Oncol Pract 2021;:OP2001010. [PMID: 34043449 DOI: 10.1200/OP.20.01010] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
45 Shindoh J. Risk stratification and goal of systemic therapy for successful surgical management of colorectal liver metastases: Oncological optimization. J Hepatobiliary Pancreat Sci 2021;28:461-9. [PMID: 33797853 DOI: 10.1002/jhbp.964] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
46 Molla M, Fernandez-Plana J, Albiol S, Fondevila C, Vollmer I, Cases C, Garcia-Criado A, Capdevila J, Conill C, Fundora Y, Fernandez-Martos C, Pineda E. Limited Liver or Lung Colorectal Cancer Metastases. Systemic Treatment, Surgery, Ablation or SBRT. J Clin Med 2021;10:2131. [PMID: 34069240 DOI: 10.3390/jcm10102131] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
47 Alam W, Bouferraa Y, Haibe Y, Mukherji D, Shamseddine A. Management of colorectal cancer in the era of COVID-19: Challenges and suggestions. Sci Prog 2021;104:368504211010626. [PMID: 33878982 DOI: 10.1177/00368504211010626] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
48 Kelm M, Schollbach J, Anger F, Wiegering A, Klein I, Germer CT, Schlegel N, Kunzmann V, Löb S. Prognostic impact of additive chemotherapy after curative resection of metachronous colorectal liver metastasis: a single-centre retrospective study. BMC Cancer 2021;21:490. [PMID: 33941104 DOI: 10.1186/s12885-021-07941-2] [Reference Citation Analysis]
49 Kellokumpu I, Kairaluoma M, Mecklin JP, Kellokumpu H, Väyrynen V, Wirta EV, Sihvo E, Kuopio T, Seppälä TT. Impact of Age and Comorbidity on Multimodal Management and Survival from Colorectal Cancer: A Population-Based Study. J Clin Med 2021;10:1751. [PMID: 33920665 DOI: 10.3390/jcm10081751] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
50 Nishino H, Hollandsworth HM, Amirfakhri S, Tashiro Y, Yamamoto J, Turner MA, Lwin TM, Singer BB, Hoffman RM, Bouvet M. A Novel Color-Coded Liver Metastasis Mouse Model to Distinguish Tumor and Adjacent Liver Segment. J Surg Res 2021;264:327-33. [PMID: 33848831 DOI: 10.1016/j.jss.2021.02.022] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
51 Nishioka Y, Kawaguchi Y, Kothari AN, Odisio BC, Vauthey JN. Prognostic and Therapeutic Implications of Tumor Biology, Including Gene Alterations, in Colorectal Liver Metastases. J Gastrointest Surg 2021;25:1591-600. [PMID: 33742360 DOI: 10.1007/s11605-021-04962-x] [Reference Citation Analysis]
52 Meijerink MR, Ruarus AH, Vroomen LGPH, Puijk RS, Geboers B, Nieuwenhuizen S, van den Bemd BAT, Nielsen K, de Vries JJJ, van Lienden KP, Lissenberg-Witte BI, van den Tol MP, Scheffer HJ. Irreversible Electroporation to Treat Unresectable Colorectal Liver Metastases (COLDFIRE-2): A Phase II, Two-Center, Single-Arm Clinical Trial. Radiology 2021;299:470-80. [PMID: 33724066 DOI: 10.1148/radiol.2021203089] [Cited by in Crossref: 3] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
53 Ratti F, Cipriani F, Fiorentini G, Burgio V, Ronzoni M, Della Corte A, Cascinu S, De Cobelli F, Aldrighetti L. Evolution of Surgical Treatment of Colorectal Liver Metastases in the Real World: Single Center Experience in 1212 Cases. Cancers (Basel) 2021;13:1178. [PMID: 33803257 DOI: 10.3390/cancers13051178] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
54 Yoh T, Perrot A, Beaufrère A, Hobeika C, Sartoris R, Paradis V, Vilgrain V, Soubrane O, Cauchy F, Ronot M. Liver surface nodularity: a novel predictor of post-hepatectomy liver failure in patients with colorectal liver metastases following chemotherapy. Eur Radiol 2021;31:5830-9. [PMID: 33666699 DOI: 10.1007/s00330-020-07683-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
55 Garcia-Vicién G, Mezheyeuski A, Bañuls M, Ruiz-Roig N, Molleví DG. The Tumor Microenvironment in Liver Metastases from Colorectal Carcinoma in the Context of the Histologic Growth Patterns. Int J Mol Sci 2021;22:1544. [PMID: 33546502 DOI: 10.3390/ijms22041544] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
56 Vigano L, Corleone P, Darwish SS, Turri N, Famularo S, Viggiani L, Rimassa L, Del Fabbro D, Di Tommaso L, Torzilli G. Hepatic and Extrahepatic Colorectal Metastases Have Discordant Responses to Systemic Therapy. Pathology Data from Patients Undergoing Simultaneous Resection of Multiple Tumor Sites. Cancers (Basel) 2021;13:464. [PMID: 33530435 DOI: 10.3390/cancers13030464] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
57 Chavez MI, Gholami S, Kim BJ, Margonis GA, Ethun CG, Tsai S, Christians KK, Clarke C, Mogal H, Maithel SK, Pawlik TM, D'Angelica MI, Aloia TA, Eastwood D, Gamblin TC. Two-Stage Hepatectomy for Bilateral Colorectal Liver Metastases: A Multi-institutional Analysis. Ann Surg Oncol 2021;28:1457-65. [PMID: 33393036 DOI: 10.1245/s10434-020-09459-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
58 Ikuta S, Aihara T, Nakajima T, Kasai M, Yamanaka N. Computed tomography-measured bone mineral density as a surrogate marker of survival after resection of colorectal liver metastases. Ann Transl Med 2021;9:21. [PMID: 33553314 DOI: 10.21037/atm-20-3751] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
59 Ostwal V, Kapoor A, Engineer R, Saklani A, deSouza A, Patil P, Arya S, Ankathi SK, Chopra S, Patil M, Jain S, Ramaswamy A. Systemic chemotherapy and short-course radiation in metastatic rectal cancers: A feasible paradigm in unresectable and potentially resectable cancers. South Asian J Cancer 2019;8:92-7. [PMID: 31069186 DOI: 10.4103/sajc.sajc_174_18] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
60 Krasnodebski M, Kim BJ, Wei SH, Velasco JD, Nishioka Y, Vauthey JN. Chemotherapy in combination with resection for colorectal liver metastases – current evidence. Surgery in Practice and Science 2020;3:100021. [DOI: 10.1016/j.sipas.2020.100021] [Reference Citation Analysis]
61 Elfrink AKE, Nieuwenhuizen S, van den Tol MP, Burgmans MC, Prevoo W, Coolsen MME, van den Boezem PB, van Delden OM, Hagendoorn J, Patijn GA, Leclercq WKG, Liem MSL, Rijken AM, Verhoef C, Kuhlmann KFD, Ruiter SJS, Grünhagen DJ, Klaase JM, Kok NFM, Meijerink MR, Swijnenburg RJ; Dutch Hepato Biliary Audit Group., Collaborators. Hospital variation in combined liver resection and thermal ablation for colorectal liver metastases and impact on short-term postoperative outcomes: a nationwide population-based study. HPB (Oxford) 2021;23:827-39. [PMID: 33218949 DOI: 10.1016/j.hpb.2020.10.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
62 Bolhuis K, Kos M, van Oijen MGH, Swijnenburg RJ, Punt CJA. Conversion strategies with chemotherapy plus targeted agents for colorectal cancer liver-only metastases: A systematic review. Eur J Cancer 2020;141:225-38. [PMID: 33189037 DOI: 10.1016/j.ejca.2020.09.037] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
63 Kobayashi K, Uldry E, Demartines N, Halkic N. Liver resections between 2014 and 2020 in the Lausanne University Hospital, Switzerland. Glob Health Med 2020;2:337-42. [PMID: 33330829 DOI: 10.35772/ghm.2020.01059] [Reference Citation Analysis]
64 Fonseca GM, Braghiroli MIFM, Pirola Kruger JA, Coelho FF, Herman P. Is There a Role for Locoregional Therapies for Non-colorectal Gastrointestinal Malignancies? Surg Oncol Clin N Am 2021;30:125-42. [PMID: 33220801 DOI: 10.1016/j.soc.2020.08.004] [Reference Citation Analysis]
65 Martin J, Petrillo A, Smyth EC, Shaida N, Khwaja S, Cheow H, Duckworth A, Heister P, Praseedom R, Jah A, Balakrishnan A, Harper S, Liau S, Kosmoliaptsis V, Huguet E. Colorectal liver metastases: Current management and future perspectives. World J Clin Oncol 2020; 11(10): 761-808 [PMID: 33200074 DOI: 10.5306/wjco.v11.i10.761] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 21] [Article Influence: 13.0] [Reference Citation Analysis]
66 Brennan VK, Colaone F, Shergill S, Pollock RF. A cost-utility analysis of SIR-Spheres Y-90 resin microspheres versus best supportive care in the treatment of unresectable metastatic colorectal cancer refractory to chemotherapy in the UK. J Med Econ 2020;23:1588-97. [PMID: 33084466 DOI: 10.1080/13696998.2020.1839273] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
67 Parmar KL, O'Reilly D, Valle JW, Braun M, Naish JH, Williams SR, Lloyd WK, Malcomson L, Cresswell K, Bamford C, Renehan AG. Prospective study of change in liver function and fat in patients with colorectal liver metastases undergoing preoperative chemotherapy: protocol for the CLiFF Study. BMJ Open 2020;10:e027630. [PMID: 32967864 DOI: 10.1136/bmjopen-2018-027630] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
68 O'Connor JM, Loria FS. Towards precision medicine in colorectal cancer liver metastases. Hepat Oncol 2020;7:HEP29. [PMID: 32774838 DOI: 10.2217/hep-2020-0011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
69 Walter T, Hawkins NS, Pollock RF, Colaone F, Shergill S, Ross PJ. Systematic review and network meta-analyses of third-line treatments for metastatic colorectal cancer. J Cancer Res Clin Oncol 2020;146:2575-87. [PMID: 32715436 DOI: 10.1007/s00432-020-03315-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
70 Russolillo N, Borello A, Langella S, Casella M, Lo Tesoriere R, Ferrero A. Comparison of laparoscopic ultrasound and liver-specific magnetic resonance imaging for staging colorectal liver metastases. Surg Endosc 2021;35:3547-53. [PMID: 32710215 DOI: 10.1007/s00464-020-07817-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
71 Petrowsky H, Fritsch R, Guckenberger M, De Oliveira ML, Dutkowski P, Clavien P. Modern therapeutic approaches for the treatment of malignant liver tumours. Nat Rev Gastroenterol Hepatol 2020;17:755-72. [DOI: 10.1038/s41575-020-0314-8] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 27.5] [Reference Citation Analysis]
72 Ratti F, Fuks D, Cipriani F, Gayet B, Aldrighetti L. Timing of Perioperative Chemotherapy Does Not Influence Long-Term Outcome of Patients Undergoing Combined Laparoscopic Colorectal and Liver Resection in Selected Upfront Resectable Synchronous Liver Metastases. World J Surg. 2019;43:3110-3119. [PMID: 31451846 DOI: 10.1007/s00268-019-05142-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
73 Račkauskas R, Baušys A, Sokolovas V, Paškonis M, Strupas K. Short- and long-term outcomes of surgery for colorectal and non-colorectal liver metastasis: a report from a single center in the Baltic country. World J Surg Oncol 2020;18:164. [PMID: 32664960 DOI: 10.1186/s12957-020-01944-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
74 Oliveira RC, Alexandrino H, Cipriano MA, Alves FC, Tralhão JG. Predicting liver metastases growth patterns: Current status and future possibilities. Semin Cancer Biol 2021;71:42-51. [PMID: 32679190 DOI: 10.1016/j.semcancer.2020.07.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
75 Nemeth Z, Wijker W, Lengyel Z, Hitre E, Borbely K. Metabolic Parameters as Predictors for Progression Free and Overall Survival of Patients with Metastatic Colorectal Cancer. Pathol Oncol Res 2020;26:2683-91. [PMID: 32661836 DOI: 10.1007/s12253-020-00865-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
76 Long GB, Xiao CW, Zhao XY, Zhang J, Li X. Effects of hepatic arterial infusion chemotherapy in the treatment of hepatocellular carcinoma: A meta-analysis. Medicine (Baltimore) 2020;99:e20745. [PMID: 32590750 DOI: 10.1097/MD.0000000000020745] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
77 Nieuwenhuizen S, Puijk RS, van den Bemd B, Aldrighetti L, Arntz M, van den Boezem PB, Bruynzeel AME, Burgmans MC, de Cobelli F, Coolsen MME, Dejong CHC, Derks S, Diederik A, van Duijvendijk P, Eker HH, Engelsman AF, Erdmann JI, Fütterer JJ, Geboers B, Groot G, Haasbeek CJA, Janssen JJ, de Jong KP, Kater GM, Kazemier G, Kruimer JWH, Leclercq WKG, van der Leij C, Manusama ER, Meier MAJ, van der Meijs BB, Melenhorst MCAM, Nielsen K, Nijkamp MW, Potters FH, Prevoo W, Rietema FJ, Ruarus AH, Ruiter SJS, Schouten EAC, Serafino GP, Sietses C, Swijnenburg RJ, Timmer FEF, Versteeg KS, Vink T, de Vries JJJ, de Wilt JHW, Zonderhuis BM, Scheffer HJ, van den Tol PMP, Meijerink MR. Resectability and Ablatability Criteria for the Treatment of Liver Only Colorectal Metastases: Multidisciplinary Consensus Document from the COLLISION Trial Group.Cancers (Basel). 2020;12. [PMID: 32635230 DOI: 10.3390/cancers12071779] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 11.0] [Reference Citation Analysis]
78 Väyrynen V, Wirta EV, Seppälä T, Sihvo E, Mecklin JP, Vasala K, Kellokumpu I. Incidence and management of patients with colorectal cancer and synchronous and metachronous colorectal metastases: a population-based study. BJS Open 2020;4:685-92. [PMID: 32543788 DOI: 10.1002/bjs5.50299] [Cited by in Crossref: 8] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
79 Pernot S, Pellerin O, Artru P, Montérymard C, Smith D, Raoul JL, De La Fouchardière C, Dahan L, Guimbaud R, Sefrioui D, Jouve JL, Lepage C, Tougeron D, Taieb J; for FFCD1201-DEBIRI investigators/Collaborators. Intra-arterial hepatic beads loaded with irinotecan (DEBIRI) with mFOLFOX6 in unresectable liver metastases from colorectal cancer: a Phase 2 study. Br J Cancer 2020;123:518-24. [PMID: 32507854 DOI: 10.1038/s41416-020-0917-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
80 Mise Y, Hasegawa K, Saiura A, Oba M, Yamamoto J, Nomura Y, Takayama T, Hashiguchi Y, Shibasaki M, Sakamoto H, Yamagata S, Aoyanagi N, Kaneko H, Koyama H, Miyagawa S, Shinozaki E, Yoshida S, Nozawa H, Kokudo N. A Multicenter Phase 2 Trial to Evaluate the Efficacy of mFOLFOX6 + Cetuximab as Induction Chemotherapy to Achieve R0 Surgical Resection for Advanced Colorectal Liver Metastases (NEXTO Trial). Ann Surg Oncol 2020;27:4188-95. [PMID: 32514802 DOI: 10.1245/s10434-020-08627-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
81 Schullian P, Putzer D, Eberle G, Laimer G, Bale R. Simultaneous Stereotactic Radiofrequency Ablation of Multiple (≥ 4) Liver Tumors: Feasibility, Safety, and Efficacy. J Vasc Interv Radiol 2020;31:943-52. [PMID: 32414570 DOI: 10.1016/j.jvir.2019.12.794] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
82 Huang Z, Lin Q, Ye X, Yang B, Zhang R, Chen H, Weng W, Kong J. Terminal deoxynucleotidyl transferase based signal amplification for enzyme-linked aptamer-sorbent assay of colorectal cancer exosomes. Talanta 2020;218:121089. [PMID: 32797865 DOI: 10.1016/j.talanta.2020.121089] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
83 Schulz A, Joelsen-Hatlehol ES, Brudvik KW, Aasand KK, Hanekamp B, Viktil E, Johansen CK, Dormagen JB. Preoperative detection of colorectal liver metastases: DWI alone or combined with MDCT is no substitute for Gd-EOB-DTPA-enhanced MRI. Acta Radiol 2020;61:302-11. [PMID: 31335157 DOI: 10.1177/0284185119864000] [Reference Citation Analysis]
84 Miura S, Ito K, Takemura N, Mihara F, Kiyomatsu T, Kokudo N. Complete remission of multiple liver metastases with only partial response of the primary rectal cancer after neoadjuvant chemotherapy. Surg Case Rep 2020;6:46. [PMID: 32107670 DOI: 10.1186/s40792-020-00807-y] [Reference Citation Analysis]
85 Raoux L, Maulat C, Mokrane FZ, Fares N, Suc B, Muscari F. Impact of the strategy for curative treatment of synchronous colorectal cancer liver metastases. J Visc Surg 2020;157:289-99. [PMID: 32089468 DOI: 10.1016/j.jviscsurg.2019.10.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
86 Adam R, Kitano Y, Abdelrafee A, Allard MA, Baba H. Debulking surgery for colorectal liver metastases: Foolish or chance? Surg Oncol 2020;33:266-9. [PMID: 32561091 DOI: 10.1016/j.suronc.2020.02.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
87 Fadaka AO, Pretorius A, Klein A. Biomarkers for Stratification in Colorectal Cancer: MicroRNAs. Cancer Control 2019;26:1073274819862784. [PMID: 31431043 DOI: 10.1177/1073274819862784] [Cited by in Crossref: 17] [Cited by in F6Publishing: 27] [Article Influence: 8.5] [Reference Citation Analysis]
88 Zamboni G, Mazzaro A, Mansueto G. How to Best Image Colorectal Liver Metastases. Curr Colorectal Cancer Rep 2020;16:11-7. [DOI: 10.1007/s11888-019-00447-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
89 Samir B, Arnab G. Colorectal Liver Metastasis: Current Concepts. Indian J Surg 2021;83:637-46. [DOI: 10.1007/s12262-019-02051-7] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
90 Araujo RLC, Sanctis MA, Barroti LC, Coelho TRV. Robotic approach as a valid strategy to improve the access to posterosuperior hepatic segments-Case series and review of literature. J Surg Oncol 2020;121:873-80. [PMID: 31912515 DOI: 10.1002/jso.25831] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
91 Robles-Campos R, Brusadin R, López-Conesa A, López-López V, Navarro-Barrios Á, López-Espín JJ, Arévalo-Pérez J, Parrilla P. Long-Term Outcome After Conventional Two-Stage Hepatectomy Versus Tourniquet-ALPPS in Colorectal Liver Metastases: A Propensity Score Matching Analysis. World J Surg 2019;43:2281-9. [PMID: 31119359 DOI: 10.1007/s00268-019-05031-w] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
92 Peng S, Ding H, Fu T, Wang B, Wang W, Zhou J. Savitzky-Golay filter based contrast-enhanced ultrasound quantification in hepatic tumors: Methodology and its correlation with tumor angiogenesis. CH 2019;73:271-82. [DOI: 10.3233/ch-180432] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
93 Araujo RLC, Milani JM, Armentano DP, Moreira RB, Pinto GSF, de Castro LA, Lucchesi FR. Disappearing colorectal liver metastases: Strategies for the management of patients achieving a radiographic complete response after systemic chemotherapy. J Surg Oncol. 2020;121:848-856. [PMID: 31773747 DOI: 10.1002/jso.25784] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
94 Shin JK, Kim HC, Lee WY, Yun SH, Cho YB, Huh JW, Park YA, Heo JS, Kim JM. Comparative study of laparoscopic versus open technique for simultaneous resection of colorectal cancer and liver metastases with propensity score analysis. Surg Endosc 2020;34:4772-80. [DOI: 10.1007/s00464-019-07253-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
95 Duran Derijckere I, Levillain H, Bohlok A, Mathey C, Nezri J, Muteganya R, Trotta N, Lucidi V, Bouazza F, Germanova D, Van Simaeys G, Goldman S, Hendlisz A, Flamen P, Donckier V. The metabolic clinical risk score as a new prognostic model for surgical decision-making in patients with colorectal liver metastases. J Surg Oncol 2019. [PMID: 31721228 DOI: 10.1002/jso.25763] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
96 Okumura S, Tabchouri N, Leung U, Tinguely P, Louvet C, Beaussier M, Gayet B, Fuks D. Laparoscopic Parenchymal-Sparing Hepatectomy for Multiple Colorectal Liver Metastases Improves Outcomes and Salvageability: A Propensity Score-Matched Analysis. Ann Surg Oncol. 2019;26:4576-4586. [PMID: 31605335 DOI: 10.1245/s10434-019-07902-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
97 Cai Y, Lu X, Zhu X, Ju H, Sun W, Wu W. Histological tumor response assessment in colorectal liver metastases after neoadjuvant chemotherapy: impact of the variation in tumor regression grading and peritumoral lymphocytic infiltration. J Cancer 2019;10:5852-61. [PMID: 31737121 DOI: 10.7150/jca.31493] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
98 Beaton L, Tregidgo HFJ, Znati SA, Forsyth S, Clarkson MJ, Bandula S, Chouhan M, Lowe HL, Zaw Thin M, Hague J, Sharma D, Pollok JM, Davidson BR, Raja J, Munneke G, Stuckey DJ, Bascal ZA, Wilde PE, Cooper S, Ryan S, Czuczman P, Boucher E, Hartley JA, Lewis AL, Jansen M, Meyer T, Sharma RA. VEROnA Protocol: A Pilot, Open-Label, Single-Arm, Phase 0, Window-of-Opportunity Study of Vandetanib-Eluting Radiopaque Embolic Beads (BTG-002814) in Patients With Resectable Liver Malignancies. JMIR Res Protoc 2019;8:e13696. [PMID: 31579027 DOI: 10.2196/13696] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
99 Lerut J, Iesari S, Vandeplas G, Fabbrizio T, Ackenine K, Núñez MEI, Komuta M, Coubeau L, Ciccarelli O, Bonaccorsi-riani E. Secondary non-resectable liver tumors: A single-center living-donor and deceased-donor liver transplantation case series. Hepatobiliary & Pancreatic Diseases International 2019;18:412-22. [DOI: 10.1016/j.hbpd.2019.08.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
100 Nadalin S, Königsrainer A, Capobianco I, Settmacher U, Rauchfuss F. Auxiliary living donor liver transplantation combined with two-stage hepatectomy for unresectable colorectal liver metastases. Current Opinion in Organ Transplantation 2019;24:651-8. [DOI: 10.1097/mot.0000000000000695] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
101 Strohäker J, Königsrainer A, Nadalin S. [Role of the radiologist in surgery of colorectal liver metastases : What should be removed and what must remain]. Radiologe 2019;59:791-8. [PMID: 31410495 DOI: 10.1007/s00117-019-0577-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
102 Huiskens J, Bolhuis K, Engelbrecht MR, De Jong KP, Kazemier G, Liem MS, Verhoef C, de Wilt JH, Punt CJ, van Gulik TM; Dutch Colorectal Cancer Group. Outcomes of Resectability Assessment of the Dutch Colorectal Cancer Group Liver Metastases Expert Panel. J Am Coll Surg 2019;229:523-532.e2. [PMID: 31520695 DOI: 10.1016/j.jamcollsurg.2019.08.1445] [Cited by in Crossref: 15] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
103 Ruzzenente A, Bagante F, Ratti F, Beal EW, Alexandrescu S, Merath K, Makris EA, Poultsides GA, Margonis GA, Weiss MJ, Popescu I, Aldrighetti L, Guglielmi A, Pawlik TM. Response to preoperative chemotherapy: impact of change in total burden score and mutational tumor status on prognosis of patients undergoing resection for colorectal liver metastases. HPB 2019;21:1230-9. [DOI: 10.1016/j.hpb.2019.01.014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
104 Symonds LK, Cohen SA. Use of perioperative chemotherapy in colorectal cancer metastatic to the liver. Gastroenterol Rep (Oxf) 2019;7:301-11. [PMID: 31687149 DOI: 10.1093/gastro/goz035] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
105 O Connor JM, Sanchez Loria F, Ardiles V, Grondona J, Sanchez P, Andriani O, Fauda M, Brancato F, Huertas E, Alvarez F, de Santibañes E. Prognostic impact of K-RAS mutational status and primary tumor location in patients undergoing resection for colorectal cancer liver metastases: an update. Future Oncol 2019;15:3149-57. [PMID: 31426677 DOI: 10.2217/fon-2019-0196] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
106 Albertsmeier M, Riedl K, Stephan AJ, Drefs M, Schiergens TS, Engel J, Angele MK, Werner J, Guba M. Improved survival after resection of colorectal liver metastases in patients with unresectable lung metastases. HPB (Oxford) 2020;22:368-75. [PMID: 31399325 DOI: 10.1016/j.hpb.2019.07.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
107 Okumura S, Goumard C, Gayet B, Fuks D, Scatton O. Laparoscopic vs open two-stage hepatectomy for bilobar colorectal liver metastases: A bi-institutional, propensity score-matched study. Surgery. 2019;166:959-966. [PMID: 31395397 DOI: 10.1016/j.surg.2019.06.019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
108 Vera R, González-Flores E, Rubio C, Urbano J, Valero Camps M, Ciampi-Dopazo JJ, Orcajo Rincón J, Morillo Macías V, Gomez Braco MA, Suarez-Artacho G. Multidisciplinary management of liver metastases in patients with colorectal cancer: a consensus of SEOM, AEC, SEOR, SERVEI, and SEMNIM.Clin Transl Oncol. 2020;22:647-662. [PMID: 31359336 DOI: 10.1007/s12094-019-02182-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 27] [Article Influence: 5.3] [Reference Citation Analysis]
109 Imai K, Adam R, Baba H. How to increase the resectability of initially unresectable colorectal liver metastases: A surgical perspective. Ann Gastroenterol Surg 2019;3:476-86. [PMID: 31549007 DOI: 10.1002/ags3.12276] [Cited by in Crossref: 13] [Cited by in F6Publishing: 22] [Article Influence: 4.3] [Reference Citation Analysis]
110 He X, Zhang Q, Feng Y, Li Z, Pan Q, Zhao Y, Zhu W, Zhang N, Zhou J, Wang L, Wang M, Liu Z, Zhu H, Shao Z, Wang L. Resection of liver metastases from breast cancer: a multicentre analysis. Clin Transl Oncol 2020;22:512-21. [PMID: 31230220 DOI: 10.1007/s12094-019-02155-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
111 Kobayashi S, Beppu T, Honda G, Yamamoto M, Takahashi K, Endo I, Hasegawa K, Kotake K, Itabashi M, Hashiguchi Y, Kotera Y, Sakamoto K, Yamaguchi T, Morita S, Tabuchi K, Miyazaki M, Sugihara K. Survival Benefit of and Indications for Adjuvant Chemotherapy for Resected Colorectal Liver Metastases-a Japanese Nationwide Survey. J Gastrointest Surg 2020;24:1244-60. [PMID: 31197683 DOI: 10.1007/s11605-019-04250-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
112 Bu Z, Lu C, Yang X, Lai H, Jiang Y, Li Y, Lin Y, Qin Y, Xiao M, Cheng C, Liu Q. Partial response after treatment with Conversion chemotherapy: A case report of a patient with colon cancer and unresectable hepatic metastases. Medicine (Baltimore) 2019;98:e15239. [PMID: 31027071 DOI: 10.1097/MD.0000000000015239] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
113 Lopez-lopez V, Robles-campos R, López-conesa A, Brusadin R, Carbonel G, Gomez-ruiz A, Ruiz JJ, Parrilla P. Surgical resection of liver metastasis in pancreatic and periampullary carcinoma. Minerva Chir 2019;74. [DOI: 10.23736/s0026-4733.18.07972-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
114 Reginelli A, Vacca G, Zanaletti N, Troiani T, Natella R, Maggialetti N, Palumbo P, Giovagnoni A, Ciardiello F, Cappabianca S. Diagnostic value/performance of radiological liver imaging during chemoterapy for gastrointestinal malignancy: a critical review. Acta Biomed 2019;90:51-61. [PMID: 31085973 DOI: 10.23750/abm.v90i5-S.8346] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
115 Serayssol C, Maulat C, Breibach F, Mokrane FZ, Selves J, Guimbaud R, Otal P, Suc B, Berard E, Muscari F. Predictive factors of histological response of colorectal liver metastases after neoadjuvant chemotherapy. World J Gastrointest Oncol 2019; 11(4): 295-309 [PMID: 31040895 DOI: 10.4251/wjgo.v11.i4.295] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
116 Wang Y, Zhao M, Zhao H, Cheng S, Bai R, Song M. MicroRNA-940 restricts the expression of metastasis-associated gene MACC1 and enhances the antitumor effect of Anlotinib on colorectal cancer. Onco Targets Ther 2019;12:2809-22. [PMID: 31114229 DOI: 10.2147/OTT.S195364] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
117 Min JH, Jang KM, Cha DI, Kang TW, Kim SH, Choi SY, Min K. Differences in early imaging features and pattern of progression on CT between intrahepatic biliary metastasis of colorectal origin and intrahepatic non-mass-forming cholangiocarcinoma in patients with extrabiliary malignancy. Abdom Radiol (NY) 2019;44:1350-60. [PMID: 30406380 DOI: 10.1007/s00261-018-1814-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
118 Shu Z, Fang S, Ding Z, Mao D, Cai R, Chen Y, Pang P, Gong X. MRI-based Radiomics nomogram to detect primary rectal cancer with synchronous liver metastases. Sci Rep. 2019;9:3374. [PMID: 30833648 DOI: 10.1038/s41598-019-39651-y] [Cited by in Crossref: 20] [Cited by in F6Publishing: 33] [Article Influence: 6.7] [Reference Citation Analysis]
119 Bonifacio C, Viganò L, Felisaz P, Lopci E, Cimino M, Poretti D, Donadon M, Pedicini V, Procopio F, Chiti A, Balzarini L, Torzilli G. Diffusion-weighted imaging and loco-regional N staging of patients with colorectal liver metastases. European Journal of Surgical Oncology 2019;45:347-52. [DOI: 10.1016/j.ejso.2018.11.018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
120 Krell RW, D'angelica MI. Treatment sequencing for simultaneous colorectal liver metastases. J Surg Oncol 2019;119:583-93. [DOI: 10.1002/jso.25424] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
121 Chen LY, Zhi Z, Wang L, Zhao YY, Deng M, Liu YH, Qin Y, Tian MM, Liu Y, Shen T, Sun LN, Li JM. NSD2 circular RNA promotes metastasis of colorectal cancer by targeting miR-199b-5p-mediated DDR1 and JAG1 signalling. J Pathol 2019;248:103-15. [PMID: 30666650 DOI: 10.1002/path.5238] [Cited by in Crossref: 38] [Cited by in F6Publishing: 52] [Article Influence: 12.7] [Reference Citation Analysis]
122 Li J, Yuan Y, Yang F, Wang Y, Zhu X, Wang Z, Zheng S, Wan D, He J, Wang J, Ba Y, Bai C, Bai L, Bai W, Bi F, Cai K, Cai M, Cai S, Chen G, Chen K, Chen L, Chen P, Chi P, Dai G, Deng Y, Ding K, Fan Q, Fang W, Fang X, Feng F, Fu C, Fu Q, Gu Y, He Y, Jia B, Jiang K, Lai M, Lan P, Li E, Li D, Li J, Li L, Li M, Li S, Li Y, Li Y, Li Z, Liang X, Liang Z, Lin F, Lin G, Liu H, Liu J, Liu T, Liu Y, Pan H, Pan Z, Pei H, Qiu M, Qu X, Ren L, Shen Z, Sheng W, Song C, Song L, Sun J, Sun L, Sun Y, Tang Y, Tao M, Wang C, Wang H, Wang J, Wang S, Wang X, Wang X, Wang Z, Wu A, Wu N, Xia L, Xiao Y, Xing B, Xiong B, Xu J, Xu J, Xu N, Xu R, Xu Z, Yang Y, Yao H, Ye Y, Yu Y, Yu Y, Yue J, Zhang J, Zhang J, Zhang S, Zhang W, Zhang Y, Zhang Z, Zhang Z, Zhao L, Zhao R, Zhou F, Zhou J, Jin J, Gu J, Shen L. Expert consensus on multidisciplinary therapy of colorectal cancer with lung metastases (2019 edition). J Hematol Oncol 2019;12:16. [PMID: 30764882 DOI: 10.1186/s13045-019-0702-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 40] [Article Influence: 7.3] [Reference Citation Analysis]
123 Ranieri G, Laforgia M, Nardulli P, Ferraiuolo S, Molinari P, Marech I, Gadaleta CD. Oxaliplatin-Based Intra-arterial Chemotherapy in Colo-Rectal Cancer Liver Metastases: A Review from Pharmacology to Clinical Application. Cancers (Basel) 2019;11:E141. [PMID: 30682873 DOI: 10.3390/cancers11020141] [Cited by in Crossref: 14] [Cited by in F6Publishing: 19] [Article Influence: 4.7] [Reference Citation Analysis]
124 Adam R, Kitano Y. Multidisciplinary approach of liver metastases from colorectal cancer. Ann Gastroenterol Surg. 2019;3:50-56. [PMID: 30697610 DOI: 10.1002/ags3.12227] [Cited by in Crossref: 43] [Cited by in F6Publishing: 52] [Article Influence: 14.3] [Reference Citation Analysis]
125 Pereyra D, Rumpf B, Ammann M, Perrodin SF, Tamandl D, Haselmann C, Stift J, Brostjan C, Laengle F, Beldi G, Gruenberger T, Starlinger P. The Combination of APRI and ALBI Facilitates Preoperative Risk Stratification for Patients Undergoing Liver Surgery After Neoadjuvant Chemotherapy. Ann Surg Oncol 2019;26:791-9. [PMID: 30617869 DOI: 10.1245/s10434-018-07125-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
126 Yasuno M, Uetake H, Ishiguro M, Mizunuma N, Komori T, Miyata G, Shiomi A, Kagimura T, Sugihara K. mFOLFOX6 plus bevacizumab to treat liver-only metastases of colorectal cancer that are unsuitable for upfront resection (TRICC0808): a multicenter phase II trial comprising the final analysis for survival. Int J Clin Oncol 2019;24:516-25. [PMID: 30612267 DOI: 10.1007/s10147-018-01393-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
127 Guo L, Fu J, Sun S, Zhu M, Zhang L, Niu H, Chen Z, Zhang Y, Guo L, Wang S. MicroRNA-143-3p inhibits colorectal cancer metastases by targeting ITGA6 and ASAP3. Cancer Sci 2019;110:805-16. [PMID: 30536996 DOI: 10.1111/cas.13910] [Cited by in Crossref: 24] [Cited by in F6Publishing: 35] [Article Influence: 8.0] [Reference Citation Analysis]
128 Gómez-España MA, Gallego J, González-Flores E, Maurel J, Páez D, Sastre J, Aparicio J, Benavides M, Feliu J, Vera R. SEOM clinical guidelines for diagnosis and treatment of metastatic colorectal cancer (2018). Clin Transl Oncol 2019;21:46-54. [PMID: 30565083 DOI: 10.1007/s12094-018-02002-w] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 3.5] [Reference Citation Analysis]
129 Ochiai T, Nishimura K, Watanabe T, Kitajima M, Nakatani A, Nagayasu K, Sakuyama N, Sato T, Kishine K, Abe Y, Nagaoka I. Impact of primary tumor location as a predictive factor in patients suffering from colorectal cancer treated with cytotoxic anticancer agents based on the collagen gel droplet-embedded drug sensitivity test. Oncol Lett. 2019;17:1842-1850. [PMID: 30675246 DOI: 10.3892/ol.2017.6960] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
130 Ochiai T, Nishimura K, Watanabe T, Kitajima M, Nakatani A, Nagayasu K, Sakuyama N, Sato T, Kishine K, Abe Y, Nagaoka I. Impact of primary tumor location as a predictive factor in patients suffering from colorectal cancer treated with cytotoxic anticancer agents based on the collagen gel droplet-embedded drug sensitivity test. Oncol Lett 2019;17:1842-50. [PMID: 30675246 DOI: 10.3892/ol.2018.9805] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
131 Zhang HY, Guo JH, Gao S, Chen H, Wang XD, Zhang PJ, Liu P, Cao G, Xu HF, Zhu LZ, Yang RJ, Li J, Zhu X. Effect of primary tumor side on survival outcomes in metastatic colorectal cancer patients after hepatic arterial infusion chemotherapy. World J Gastrointest Oncol 2018; 10(11): 431-438 [PMID: 30487954 DOI: 10.4251/wjgo.v10.i11.431] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
132 Ardito F, Panettieri E, Vellone M, Ferrucci M, Coppola A, Silvestrini N, Arena V, Adducci E, Capelli G, Vecchio FM, Giovannini I, Nuzzo G, Giuliante F. The impact of R1 resection for colorectal liver metastases on local recurrence and overall survival in the era of modern chemotherapy: An analysis of 1,428 resection areas. Surgery 2019;165:712-20. [PMID: 30482518 DOI: 10.1016/j.surg.2018.09.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
133 Granata V, Fusco R, Avallone A, Catalano O, Piccirillo M, Palaia R, Nasti G, Petrillo A, Izzo F. A radiologist's point of view in the presurgical and intraoperative setting of colorectal liver metastases. Future Oncol 2018;14:2189-206. [PMID: 30084273 DOI: 10.2217/fon-2018-0080] [Cited by in Crossref: 6] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
134 Madkhali A, Alalem F, Aljuhani G, Alsharaabi A, Alsaif F, Hassanain M. Preoperative Selection and Optimization for Liver Resection in Colorectal Cancer Liver Metastases. Curr Colorectal Cancer Rep 2018;14:89-97. [DOI: 10.1007/s11888-018-0405-x] [Reference Citation Analysis]
135 Takamoto T, Sano K, Hashimoto T, Ichida A, Shimada K, Maruyama Y, Makuuchi M. Practical Contribution of Virtual Hepatectomy for Colorectal Liver Metastases: a Propensity-Matched Analysis of Clinical Outcome.J Gastrointest Surg. 2018;22:2037-2044. [PMID: 29980979 DOI: 10.1007/s11605-018-3860-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
136 Foubert F, Gouard S, Saï-Maurel C, Chérel M, Faivre-Chauvet A, Goldenberg DM, Barbet J, Bailly C, Bodet-Milin C, Carlier T, Kraeber-Bodéré F, Touchefeu Y, Frampas E. Sensitivity of pretargeted immunoPET using 68Ga-peptide to detect colonic carcinoma liver metastases in a murine xenograft model: Comparison with 18FDG PET-CT. Oncotarget 2018;9:27502-13. [PMID: 29938001 DOI: 10.18632/oncotarget.25514] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
137 Krüger JAP, Fonseca GM, Makdissi FF, Jeismann VB, Coelho FF, Herman P. Evolution in the surgical management of colorectal liver metastases: Propensity score matching analysis (PSM) on the impact of specialized multidisciplinary care across two institutional eras. J Surg Oncol 2018;118:50-60. [PMID: 29878362 DOI: 10.1002/jso.25098] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
138 Donadon M, Lleo A, Di Tommaso L, Soldani C, Franceschini B, Roncalli M, Torzilli G. The Shifting Paradigm of Prognostic Factors of Colorectal Liver Metastases: From Tumor-Centered to Host Immune-Centered Factors. Front Oncol 2018;8:181. [PMID: 29892573 DOI: 10.3389/fonc.2018.00181] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
139 Sivesgaard K, Larsen LP, Sørensen M, Kramer S, Schlander S, Amanavicius N, Bharadwaz A, Tønner Nielsen D, Viborg Mortensen F, Morre Pedersen E. Diagnostic accuracy of CE-CT, MRI and FDG PET/CT for detecting colorectal cancer liver metastases in patients considered eligible for hepatic resection and/or local ablation. Eur Radiol 2018;28:4735-47. [PMID: 29736846 DOI: 10.1007/s00330-018-5469-0] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 6.8] [Reference Citation Analysis]
140 Arnold D, Lueza B, Douillard JY, Peeters M, Lenz HJ, Venook A, Heinemann V, Van Cutsem E, Pignon JP, Tabernero J, Cervantes A, Ciardiello F. Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials. Ann Oncol 2017;28:1713-29. [PMID: 28407110 DOI: 10.1093/annonc/mdx175] [Cited by in Crossref: 372] [Cited by in F6Publishing: 413] [Article Influence: 93.0] [Reference Citation Analysis]
141 Huxley N, Crathorne L, Varley-Campbell J, Tikhonova I, Snowsill T, Briscoe S, Peters J, Bond M, Napier M, Hoyle M. The clinical effectiveness and cost-effectiveness of cetuximab (review of technology appraisal no. 176) and panitumumab (partial review of technology appraisal no. 240) for previously untreated metastatic colorectal cancer: a systematic review and economic evaluation. Health Technol Assess 2017;21:1-294. [PMID: 28682222 DOI: 10.3310/hta21380] [Cited by in Crossref: 15] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
142 Franco P, De Bari B, Ciammella P, Fiorentino A, Chiesa S, Amelio D, Pinzi V, Bonomo P, Vagge S, Fiore M, Comito T, Cecconi A, Mortellaro G, Bruni A, Trovo' M, Filippi AR, Greto D, Alongi F. The Role of Stereotactic Ablative Radiotherapy in Oncological and Non-Oncological Clinical Settings: Highlights from the 7 th Meeting of AIRO – Young Members Working Group (AIRO Giovani). Tumori Journal 2018;100:e214-29. [DOI: 10.1177/1778.19280] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 2.8] [Reference Citation Analysis]
143 Falcão D, Alexandrino H, Caetano Oliveira R, Martins J, Ferreira L, Martins R, Serôdio M, Martins M, Tralhão JG, Cipriano MA, Castro E Sousa F. Histopathologic patterns as markers of prognosis in patients undergoing hepatectomy for colorectal cancer liver metastases - Pushing growth as an independent risk factor for decreased survival. Eur J Surg Oncol 2018;44:1212-9. [PMID: 29691114 DOI: 10.1016/j.ejso.2018.03.023] [Cited by in Crossref: 8] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
144 Li W, Chang J, Tong D, Peng J, Huang D, Guo W, Zhang W, Li J. Differential microRNA expression profiling in primary tumors and matched liver metastasis of patients with colorectal cancer. Oncotarget 2017;8:35783-91. [PMID: 28415758 DOI: 10.18632/oncotarget.16206] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
145 López RI, Castro JL, Cedeño H, Cisneros D, Corrales L, González-Herrera I, Lima-Pérez M, Prestol R, Salinas R, Soriano-García JL, T Zavala A, Zetina LM, Zúñiga-Orlich CE. Consensus on management of metastatic colorectal cancer in Central America and the Caribbean: San José, Costa Rica, August 2016. ESMO Open 2018;3:e000315. [PMID: 29636987 DOI: 10.1136/esmoopen-2017-000315] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
146 Tikhonova IA, Huxley N, Snowsill T, Crathorne L, Varley-campbell J, Napier M, Hoyle M. Economic Analysis of First-Line Treatment with Cetuximab or Panitumumab for RAS Wild-Type Metastatic Colorectal Cancer in England. PharmacoEconomics 2018;36:837-51. [DOI: 10.1007/s40273-018-0630-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
147 Vigano L, Darwish SS, Rimassa L, Cimino M, Carnaghi C, Donadon M, Procopio F, Personeni N, Del Fabbro D, Santoro A, Torzilli G. Progression of Colorectal Liver Metastases from the End of Chemotherapy to Resection: A New Contraindication to Surgery? Ann Surg Oncol 2018;25:1676-85. [PMID: 29488188 DOI: 10.1245/s10434-018-6387-8] [Cited by in Crossref: 19] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
148 Viganò L, Pedicini V, Comito T, Carnaghi C, Costa G, Poretti D, Franzese C, Personeni N, Del Fabbro D, Rimassa L, Scorsetti M, Santoro A, Solbiati L, Torzilli G. Aggressive and Multidisciplinary Local Approach to Iterative Recurrences of Colorectal Liver Metastases. World J Surg 2018;42:2651-9. [DOI: 10.1007/s00268-018-4525-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
149 Pellino G, Warren O, Mills S, Rasheed S, Tekkis PP, Kontovounisios C. Comparison of Western and Asian Guidelines Concerning the Management of Colon Cancer. Diseases of the Colon & Rectum 2018;61:250-9. [DOI: 10.1097/dcr.0000000000001012] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
150 Engstrand J, Nilsson H, Strömberg C, Jonas E, Freedman J. Colorectal cancer liver metastases - a population-based study on incidence, management and survival. BMC Cancer 2018;18:78. [PMID: 29334918 DOI: 10.1186/s12885-017-3925-x] [Cited by in Crossref: 172] [Cited by in F6Publishing: 269] [Article Influence: 43.0] [Reference Citation Analysis]
151 Strandberg Holka P, Eriksson S, Eberhard J, Bergenfeldt M, Lindell G, Sturesson C. Significance of poor performance status after resection of colorectal liver metastases. World J Surg Oncol. 2018;16:3. [PMID: 29304822 DOI: 10.1186/s12957-017-1306-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
152 Liu W, Zhou JG, Sun Y, Zhang L, Xing BC. The role of neoadjuvant chemotherapy for resectable colorectal liver metastases: a systematic review and meta-analysis. Oncotarget. 2016;7:37277-37287. [PMID: 27074564 DOI: 10.18632/oncotarget.8671] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 4.5] [Reference Citation Analysis]
153 Ponomarenko AA, Achkasov SI, Panina MV, Rybakov EG. SIMULTANEOUS RESECTIONS FOR SYNCHRONOUS COLORECTAL CANCER LIVER METASTASES. Koloproktologiâ 2017. [DOI: 10.33878/2073-7556-2017-0-4-45-53] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
154 Padickakudy R, Pereyra D, Offensperger F, Jonas P, Oehlberger L, Schwarz C, Haegele S, Assinger A, Brostjan C, Gruenberger T, Starlinger P. Bivalent role of intra-platelet serotonin in liver regeneration and tumor recurrence in humans. Journal of Hepatology 2017;67:1243-52. [DOI: 10.1016/j.jhep.2017.08.009] [Cited by in Crossref: 28] [Cited by in F6Publishing: 33] [Article Influence: 5.6] [Reference Citation Analysis]
155 Qin S, Chen Y, Liu X, Cheng W, Yu J, Zhang W, Jiang Q, Wang Y, Wen Y, Liu G. Clinical Application of Contrast-Enhanced Ultrasound Using High-Frequency Linear Probe in the Detection of Small Colorectal Liver Metastases. Ultrasound in Medicine & Biology 2017;43:2765-73. [DOI: 10.1016/j.ultrasmedbio.2017.08.932] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
156 Omichi K, Shindoh J, Cloyd JM, Mizuno T, Chun YS, Conrad C, Aloia TA, Tzeng CD, Vauthey JN. Liver resection is justified for patients with bilateral multiple colorectal liver metastases: A propensity-score-matched analysis. Eur J Surg Oncol. 2018;44:122-129. [PMID: 29208318 DOI: 10.1016/j.ejso.2017.11.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
157 Makowiec F, Bronsert P, Klock A, Hopt UT, Neeff HP. Prognostic influence of hepatic margin after resection of colorectal liver metastasis: role of modern preoperative chemotherapy. Int J Colorectal Dis. 2018;33:71-78. [PMID: 29098384 DOI: 10.1007/s00384-017-2916-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
158 Pędziwiatr M, Mizera M, Witowski J, Major P, Torbicz G, Gajewska N, Budzyński A. Primary tumor resection in stage IV unresectable colorectal cancer: what has changed? Med Oncol 2017;34:188. [PMID: 29086041 DOI: 10.1007/s12032-017-1047-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
159 Haraldsdottir S, Goldberg RM. Conversion Therapy for Initially Borderline/Unresectable Metastases in Colon Cancer: What Is the Best Neoadjuvant Chemotherapy? Curr Colorectal Cancer Rep 2017;13:419-28. [DOI: 10.1007/s11888-017-0393-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
160 Xu D, Liu XF, Yan XL, Wang K, Xing BC. Survival prediction in patients with resectable colorectal liver metastases: Clinical risk scores and tumor response to chemotherapy. Oncol Lett 2017;14:8051-9. [PMID: 29344248 DOI: 10.3892/ol.2017.7191] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
161 Ponomarenko AA, Shelygin YA, Rybakov EG, Achkasov SI. SIMULTANEOUS AND STAGED RESECTIONS FOR SYNCHRONOUS COLORECTAL LIVER METASTASES: META-ANALYSIS. Koloproktologiâ 2017. [DOI: 10.33878/2073-7556-2017-0-3-6-21] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
162 Mao R, Zhao JJ, Bi XY, Zhang YF, Li ZY, Zhou JG, Wu XL, Xiao C, Zhao H, Cai JQ. A postoperative scoring system for post-hepatectomy early recurrence of colorectal liver metastases. Oncotarget 2017;8:102531-9. [PMID: 29254268 DOI: 10.18632/oncotarget.20934] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
163 Tosi F, Magni E, Amatu A, Mauri G, Bencardino K, Truini M, Veronese S, De Carlis L, Ferrari G, Nichelatti M, Sartore-bianchi A, Siena S. Effect of KRAS and BRAF Mutations on Survival of Metastatic Colorectal Cancer After Liver Resection: A Systematic Review and Meta-Analysis. Clinical Colorectal Cancer 2017;16:e153-63. [DOI: 10.1016/j.clcc.2017.01.004] [Cited by in Crossref: 57] [Cited by in F6Publishing: 69] [Article Influence: 11.4] [Reference Citation Analysis]
164 Gwiasda J, Schrem H, Kaltenborn A, Mahlmann J, Mix H, Lehner F, Kayser N, Klempnauer J, Kulik U. Introduction of the resection severity index as independent risk factor limiting survival after resection of colorectal liver metastases. Surg Oncol 2017;26:382-8. [PMID: 29113656 DOI: 10.1016/j.suronc.2017.08.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
165 Baur J, Büntemeyer TO, Megerle F, Deutschbein T, Spitzweg C, Quinkler M, Nawroth P, Kroiss M, Germer CT, Fassnacht M, Steger U; German Adrenocortical Carcinoma Study Group. Outcome after resection of Adrenocortical Carcinoma liver metastases: a retrospective study. BMC Cancer 2017;17:522. [PMID: 28778197 DOI: 10.1186/s12885-017-3506-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
166 Allard MA, Adam R, Giuliante F, Lapointe R, Hubert C, Ijzermans JNM, Mirza DF, Elias D, Laurent C, Gruenberger T, Poston G, Letoublon C, Isoniemi H, Lucidi V, Popescu I, Figueras J. Long-term outcomes of patients with 10 or more colorectal liver metastases. Br J Cancer. 2017;117:604-611. [PMID: 28728167 DOI: 10.1038/bjc.2017.218] [Cited by in Crossref: 26] [Cited by in F6Publishing: 36] [Article Influence: 5.2] [Reference Citation Analysis]
167 Salvador-Rosés H, López-Ben S, Planellas P, Canals E, Casellas-Robert M, Farrés R, Ramos E, Codina-Cazador A, Figueras J. Treatment strategies for rectal cancer with synchronous liver metastases: surgical and oncological outcomes with propensity-score analysis. Clin Transl Oncol 2018;20:221-9. [PMID: 28707036 DOI: 10.1007/s12094-017-1712-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
168 Vigano L, De Rosa G, Toso C, Andres A, Ferrero A, Roth A, Sperti E, Majno P, Rubbia-brandt L. Reversibility of chemotherapy-related liver injury. Journal of Hepatology 2017;67:84-91. [DOI: 10.1016/j.jhep.2017.02.031] [Cited by in Crossref: 36] [Cited by in F6Publishing: 46] [Article Influence: 7.2] [Reference Citation Analysis]
169 Golse N, Adam R. Liver Metastases From Breast Cancer: What Role for Surgery? Indications and Results. Clinical Breast Cancer 2017;17:256-65. [DOI: 10.1016/j.clbc.2016.12.012] [Cited by in Crossref: 24] [Cited by in F6Publishing: 32] [Article Influence: 4.8] [Reference Citation Analysis]
170 Torzilli G, Viganò L, Gatti A, Costa G, Cimino M, Procopio F, Donadon M, Del Fabbro D. Twelve-year experience of "radical but conservative" liver surgery for colorectal metastases: impact on surgical practice and oncologic efficacy. HPB (Oxford) 2017;19:775-84. [PMID: 28625391 DOI: 10.1016/j.hpb.2017.05.006] [Cited by in Crossref: 36] [Cited by in F6Publishing: 45] [Article Influence: 7.2] [Reference Citation Analysis]
171 Kanoria S, Robertson FP, Mehta NN, Fusai G, Sharma D, Davidson BR. Effect of Remote Ischaemic Preconditioning on Liver Injury in Patients Undergoing Major Hepatectomy for Colorectal Liver Metastasis: A Pilot Randomised Controlled Feasibility Trial. World J Surg. 2017;41:1322-1330. [PMID: 27933431 DOI: 10.1007/s00268-016-3823-4] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 5.2] [Reference Citation Analysis]
172 Ellebæk SB, Fristrup CW, Mortensen MB. Intraoperative Ultrasound as a Screening Modality for the Detection of Liver Metastases during Resection of Primary Colorectal Cancer - A Systematic Review. Ultrasound Int Open 2017;3:E60-8. [PMID: 28597000 DOI: 10.1055/s-0043-100503] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
173 Adam R, Yi B, Innominato PF, Barroso E, Laurent C, Giuliante F, Capussotti L, Lapointe R, Regimbeau J, Lopez-ben S, Isoniemi H, Hubert C, Lin J, Gruenberger T, Elias D, Skipenko OG, Guglielmi A. Resection of colorectal liver metastases after second-line chemotherapy: is it worthwhile? A LiverMetSurvey analysis of 6415 patients. European Journal of Cancer 2017;78:7-15. [DOI: 10.1016/j.ejca.2017.03.009] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 4.8] [Reference Citation Analysis]
174 Engstrand J, Kartalis N, Strömberg C, Broberg M, Stillström A, Lekberg T, Jonas E, Freedman J, Nilsson H. The Impact of a Hepatobiliary Multidisciplinary Team Assessment in Patients with Colorectal Cancer Liver Metastases: A Population-Based Study. Oncologist 2017;22:1067-74. [PMID: 28550028 DOI: 10.1634/theoncologist.2017-0028] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
175 Sasaki K, Margonis GA, Andreatos N, Zhang X, Buettner S, Wang J, Deshwar A, He J, Wolfgang CL, Weiss M, Pawlik TM. The prognostic utility of the “Tumor Burden Score” based on preoperative radiographic features of colorectal liver metastases. J Surg Oncol 2017;116:515-23. [DOI: 10.1002/jso.24678] [Cited by in Crossref: 13] [Cited by in F6Publishing: 28] [Article Influence: 2.6] [Reference Citation Analysis]
176 Donadon M, Hudspeth K, Cimino M, Di Tommaso L, Preti M, Tentorio P, Roncalli M, Mavilio D, Torzilli G. Increased Infiltration of Natural Killer and T Cells in Colorectal Liver Metastases Improves Patient Overall Survival. J Gastrointest Surg. 2017;21:1226-1236. [PMID: 28536806 DOI: 10.1007/s11605-017-3446-6] [Cited by in Crossref: 36] [Cited by in F6Publishing: 42] [Article Influence: 7.2] [Reference Citation Analysis]
177 Azoulay D, Bhangui P, Pascal G, Salloum C, Andreani P, Ichai P, Saliba F, Lim C. The impact of expanded indications on short-term outcomes for resection of malignant tumours of the liver over a 30 year period. HPB (Oxford) 2017;19:638-48. [PMID: 28495439 DOI: 10.1016/j.hpb.2017.04.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
178 Hosokawa I, Allard MA, Mirza DF, Kaiser G, Barroso E, Lapointe R, Laurent C, Ferrero A, Miyazaki M, Adam R. Outcomes of parenchyma-preserving hepatectomy and right hepatectomy for solitary small colorectal liver metastasis: A LiverMetSurvey study. Surgery. 2017;162:223-232. [PMID: 28434557 DOI: 10.1016/j.surg.2017.02.012] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
179 McPartlin A, Swaminath A, Wang R, Pintilie M, Brierley J, Kim J, Ringash J, Wong R, Dinniwell R, Craig T, Dawson LA. Long-Term Outcomes of Phase 1 and 2 Studies of SBRT for Hepatic Colorectal Metastases. Int J Radiat Oncol Biol Phys. 2017;99:388-395. [PMID: 28871989 DOI: 10.1016/j.ijrobp.2017.04.010] [Cited by in Crossref: 30] [Cited by in F6Publishing: 37] [Article Influence: 6.0] [Reference Citation Analysis]
180 Giuliani J, Bonetti A. The Pharmacological Costs of Complete Liver Resections in Unselected Advanced Colorectal Cancer Patients: Focus on Targeted Agents. A Review of Randomized Clinical Trials. J Gastrointest Cancer 2016;47:341-50. [PMID: 27488729 DOI: 10.1007/s12029-016-9862-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
181 Nishioka Y, Shindoh J, Yoshioka R, Gonoi W, Abe H, Okura N, Yoshida S, Sakamoto Y, Hasegawa K, Fukayama M, Kokudo N. Clinical Impact of Preoperative Chemotherapy on Microscopic Cancer Spread Surrounding Colorectal Liver Metastases. Ann Surg Oncol 2017;24:2326-33. [PMID: 28349338 DOI: 10.1245/s10434-017-5845-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
182 Torres OJ, Marques MC, Santos FN, Farias IC, Coutinho AK, Oliveira CV, Kalil AN, Mello CA, Kruger JA, Fernandes GD, Quireze C Jr, Murad AM, Silva MJ, Zurstrassen CE, Freitas HC, Cruz MR, Weschenfelder R, Linhares MM, Castro LD, Vollmer C, Dixon E, Ribeiro HS, Coimbra FJ. BRAZILIAN CONSENSUS FOR MULTIMODAL TREATMENT OF COLORECTAL LIVER METASTASES. MODULE 3: CONTROVERSIES AND UNRESECTABLE METASTASES. Arq Bras Cir Dig 2016;29:173-9. [PMID: 27759781 DOI: 10.1590/0102-6720201600030011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
183 Jones RP, Brudvik KW, Franklin JM, Poston GJ. Precision surgery for colorectal liver metastases: Opportunities and challenges of omics-based decision making. Eur J Surg Oncol. 2017;43:875-883. [PMID: 28302330 DOI: 10.1016/j.ejso.2017.02.014] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 3.6] [Reference Citation Analysis]
184 Kang KA, Jang KM, Kim SH, Kang TW, Cha DI. Risk factor assessment to predict the likelihood of a diagnosis of metastasis for indeterminate hepatic lesions found at computed tomography in patients with rectal cancer. Clin Radiol 2017;72:473-81. [PMID: 28258741 DOI: 10.1016/j.crad.2017.01.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
185 Kemeny NE, Rau B. Oligometastases of Gastrointestinal Cancer Origin. Visc Med 2017;33:8-9. [PMID: 28612012 DOI: 10.1159/000458718] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
186 Song P, Sheng L, Sun Y, An Y, Guo Y, Zhang Y. The clinical utility and outcomes of microwave ablation for colorectal cancer liver metastases. Oncotarget 2017;8:51792-9. [PMID: 28881688 DOI: 10.18632/oncotarget.15244] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
187 Reddy SK, Boland PM, Nurkin SJ. Primary tumor resection does not improve survival among patients with unresectable colorectal cancer metastases-But who determines resectability? Cancer 2017;123:1089-91. [PMID: 28178383 DOI: 10.1002/cncr.30595] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
188 Mocellin S, Baretta Z, Roqué I Figuls M, Solà I, Martin-Richard M, Hallum S, Bonfill Cosp X. Second-line systemic therapy for metastatic colorectal cancer. Cochrane Database Syst Rev 2017;1:CD006875. [PMID: 28128439 DOI: 10.1002/14651858.CD006875.pub3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
189 Zhang H, Guo J, Gao S, Zhang P, Chen H, Wang X, Li X, Zhu X. Prognostic factors for transarterial chemoembolization combined with sustained oxaliplatin-based hepatic arterial infusion chemotherapy of colorectal cancer liver metastasis. Chin J Cancer Res. 2017;29:36-44. [PMID: 28373752 DOI: 10.21147/j.issn.1000-9604.2017.01.05] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
190 Griseri G, Ceriotti M, Percivale A, Franceschi A, Santori G, Benasso M, Pellicci R. Two-stage hepatectomy in two regional district community hospitals: perioperative safety and long-term survival. Tumori 2017;103:170-6. [PMID: 28058712 DOI: 10.5301/tj.5000589] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
191 Di Carlo S, Yeung D, Mills J, Zaitoun A, Cameron I, Gomez D. Resection margin influences the outcome of patients with bilobar colorectal liver metastases. World J Hepatol 2016; 8(34): 1502-1510 [PMID: 28008341 DOI: 10.4254/wjh.v8.i34.1502] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
192 Wylie N, Hider P, Armstrong D, Rajkomar K, Srinivasa S, Rodgers M, Brown A, Koea J. From scratch: developing a hepatic resection service for metastatic colorectal cancer: Developing a hepatic resection service. ANZ J Surg 2018;88:E377-81. [DOI: 10.1111/ans.13848] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
193 Elias D, Viganò L, Orsi F, Scorsetti M, Comito T, Lerut J, Cosola D, Torzilli G. New Perspectives in the Treatment of Colorectal Metastases. Liver Cancer 2016;6:90-8. [PMID: 27995093 DOI: 10.1159/000449492] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
194 Jones RP, Kokudo N, Folprecht G, Mise Y, Unno M, Malik HZ, Fenwick SW, Poston GJ. Colorectal Liver Metastases: A Critical Review of State of the Art. Liver Cancer 2016;6:66-71. [PMID: 27995090 DOI: 10.1159/000449348] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 7.2] [Reference Citation Analysis]
195 Chen Y, Xie Y, Xu L, Zhan S, Xiao Y, Gao Y, Wu B, Ge W. Protein content and functional characteristics of serum-purified exosomes from patients with colorectal cancer revealed by quantitative proteomics. Int J Cancer. 2017;140:900-913. [PMID: 27813080 DOI: 10.1002/ijc.30496] [Cited by in Crossref: 67] [Cited by in F6Publishing: 77] [Article Influence: 11.2] [Reference Citation Analysis]
196 Viganò L, Lopci E, Costa G, Rodari M, Poretti D, Pedicini V, Solbiati L, Chiti A, Torzilli G. Positron Emission Tomography-Computed Tomography for Patients with Recurrent Colorectal Liver Metastases: Impact on Restaging and Treatment Planning. Ann Surg Oncol 2017;24:1029-36. [DOI: 10.1245/s10434-016-5644-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
197 Gandy RC, Stavrakis T, Haghighi KS. Short- and long-term outcomes of elderly patients undergoing liver resection for colorectal liver metastasis. ANZ J Surg 2018;88:E103-7. [PMID: 27796073 DOI: 10.1111/ans.13690] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
198 Araujo RL, Riechelmann RP, Fong Y. Patient selection for the surgical treatment of resectable colorectal liver metastases. J Surg Oncol. 2017;115:213-220. [PMID: 27778357 DOI: 10.1002/jso.24482] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
199 Krell D, Glynne-jones R. Ongoing Adjuvant/Neoadjuvant Trials in Resectable Metastatic Colorectal Cancer. Curr Colorectal Cancer Rep 2016;12:303-13. [DOI: 10.1007/s11888-016-0342-5] [Reference Citation Analysis]
200 Viganò L, Torzilli G, Cimino M, Imai K, Vibert E, Donadon M, Castaing D, Adam R. Drop-out between the two liver resections of two-stage hepatectomy. Patient selection or loss of chance? European Journal of Surgical Oncology (EJSO) 2016;42:1385-93. [DOI: 10.1016/j.ejso.2016.03.020] [Cited by in Crossref: 30] [Cited by in F6Publishing: 34] [Article Influence: 5.0] [Reference Citation Analysis]
201 Reiter MJ, Hannemann NP, Schwope RB, Lisanti CJ, Learn PA. Role of imaging for patients with colorectal hepatic metastases: what the radiologist needs to know. Abdom Imaging 2015;40:3029-42. [PMID: 26194812 DOI: 10.1007/s00261-015-0507-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
202 Ntourakis D, Memeo R, Soler L, Marescaux J, Mutter D, Pessaux P. Augmented Reality Guidance for the Resection of Missing Colorectal Liver Metastases: An Initial Experience. World J Surg. 2016;40:419-426. [PMID: 26316112 DOI: 10.1007/s00268-015-3229-8] [Cited by in Crossref: 40] [Cited by in F6Publishing: 48] [Article Influence: 6.7] [Reference Citation Analysis]
203 Ntourakis D, Memeo R, Soler L, Marescaux J, Mutter D, Pessaux P. Augmented Reality Guidance for the Resection of Missing Colorectal Liver Metastases: An Initial Experience. World J Surg. 2016;40:419-426. [PMID: 26316112 DOI: 10.1007/-s00268-015-3229-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
204 Karaosmanoglu AD, Onur MR, Ozmen MN, Akata D, Karcaaltincaba M. Magnetic Resonance Imaging of Liver Metastasis. Semin Ultrasound CT MR. 2016;37:533-548. [PMID: 27986172 DOI: 10.1053/j.sult.2016.08.005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 3.8] [Reference Citation Analysis]
205 Li W, Chang J, Wang S, Liu X, Peng J, Huang D, Sun M, Chen Z, Zhang W, Guo W. miRNA-99b-5p suppresses liver metastasis of colorectal cancer by down-regulating mTOR. Oncotarget. 2015;6:24448-24462. [PMID: 26259252 DOI: 10.18632/oncotarget.4423] [Cited by in Crossref: 49] [Cited by in F6Publishing: 59] [Article Influence: 8.2] [Reference Citation Analysis]
206 Untereiner X, Cagniet A, Memeo R, Tzedakis S, Piardi T, Severac F, Mutter D, Kianmanesh R, Marescaux J, Sommacale D, Pessaux P. Laparoscopic hepatectomy versus open hepatectomy for colorectal cancer liver metastases: comparative study with propensity score matching. Hepatobiliary Surg Nutr 2016;5:290-9. [PMID: 27500141 DOI: 10.21037/hbsn.2015.12.06] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
207 Van Cutsem E, Cervantes A, Adam R, Sobrero A, Van Krieken J, Aderka D, Aranda Aguilar E, Bardelli A, Benson A, Bodoky G, Ciardiello F, D'hoore A, Diaz-rubio E, Douillard J, Ducreux M, Falcone A, Grothey A, Gruenberger T, Haustermans K, Heinemann V, Hoff P, Köhne C, Labianca R, Laurent-puig P, Ma B, Maughan T, Muro K, Normanno N, Österlund P, Oyen W, Papamichael D, Pentheroudakis G, Pfeiffer P, Price T, Punt C, Ricke J, Roth A, Salazar R, Scheithauer W, Schmoll H, Tabernero J, Taïeb J, Tejpar S, Wasan H, Yoshino T, Zaanan A, Arnold D. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Annals of Oncology 2016;27:1386-422. [DOI: 10.1093/annonc/mdw235] [Cited by in Crossref: 1387] [Cited by in F6Publishing: 1614] [Article Influence: 231.2] [Reference Citation Analysis]
208 Lau LF, Murone C, Williams DS, Standish R, Lee ST, Christophi C, Scott AM, Muralidharan V. Metabolic response evaluation for colorectal liver metastases and correlation to pathologic response and tumour markers. ANZ J Surg 2018;88:E108-13. [PMID: 27452367 DOI: 10.1111/ans.13680] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
209 Lee DH, Lee JM. Whole-body PET/MRI for colorectal cancer staging: Is it the way forward?: Whole-Body PET/MRI for Colorectal Cancer. J Magn Reson Imaging 2017;45:21-35. [DOI: 10.1002/jmri.25337] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
210 Wu ZB, Si ZM, Qian S, Liu LX, Qu XD, Zhou B, Zhang W, Wang GZ, Liu R, Wang JH. Percutaneous microwave ablation combined with synchronous transcatheter arterial chemoembolization for the treatment of colorectal liver metastases: results from a follow-up cohort. Onco Targets Ther 2016;9:3783-9. [PMID: 27382314 DOI: 10.2147/OTT.S105192] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
211 Nardo B, Serafini S, Ruggiero M, Grande R, Fugetto F, Zullo A, Novello M, Rizzuto A, Bonaiuto E, Vaccarisi S. Liver resection for metastases from colorectal cancer in very elderly patients: New surgical horizons. Int J Surg. 2016;33 Suppl 1:S135-S141. [PMID: 27353843 DOI: 10.1016/j.ijsu.2016.06.014] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
212 Giglio MC, Giakoustidis A, Draz A, Jawad ZAR, Pai M, Habib NA, Tait P, Frampton AE, Jiao LR. Oncological Outcomes of Major Liver Resection Following Portal Vein Embolization: A Systematic Review and Meta-analysis. Ann Surg Oncol. 2016;23:3709-3717. [PMID: 27272106 DOI: 10.1245/s10434-016-5264-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
213 Jung SW, Kim DS, Yu YD, Han JH, Suh SO. Risk factors for cancer recurrence or death within 6 months after liver resection in patients with colorectal cancer liver metastasis. Ann Surg Treat Res 2016;90:257-64. [PMID: 27186570 DOI: 10.4174/astr.2016.90.5.257] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
214 Martins J, Alexandrino H, Oliveira R, Cipriano M, Falcão D, Ferreira L, Martins R, Serôdio M, Martins M, Tralhão J, Prado e Castro L, Castro e Sousa F. Sinusoidal dilation increases the risk of complications in hepatectomy for CRCLM – Protective effect of bevacizumab and diabetes mellitus, serum gamma-glutamyltranspeptidase as predictive factor. European Journal of Surgical Oncology (EJSO) 2016;42:713-21. [DOI: 10.1016/j.ejso.2016.02.017] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
215 Imai K, Allard MA, Benitez CC, Vibert E, Sa Cunha A, Cherqui D, Castaing D, Bismuth H, Baba H, Adam R. Early Recurrence After Hepatectomy for Colorectal Liver Metastases: What Optimal Definition and What Predictive Factors? Oncologist. 2016;21:887-894. [PMID: 27125753 DOI: 10.1634/theoncologist.2015-0468] [Cited by in Crossref: 42] [Cited by in F6Publishing: 47] [Article Influence: 7.0] [Reference Citation Analysis]
216 Paniccia A, Schulick RD. Surgical Margin in Hepatic Resections for Colorectal Metastasis: Should We Care? Curr Colorectal Cancer Rep 2016;12:180-7. [DOI: 10.1007/s11888-016-0323-8] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
217 Sabanathan D, Eslick GD, Shannon J. Use of Neoadjuvant Chemotherapy Plus Molecular Targeted Therapy in Colorectal Liver Metastases: A Systematic Review and Meta-analysis. Clin Colorectal Cancer. 2016;15:e141-e147. [PMID: 27174607 DOI: 10.1016/j.clcc.2016.03.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
218 Lianos GD, Glantzounis GK. Synchronous colorectal liver metastases: treatment dilemmas and hopes for improving oncological outcomes. Future Oncol 2016;12:1743-6. [PMID: 27020479 DOI: 10.2217/fon-2016-0060] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
219 Allison RR. Fluorescence guided resection (FGR): A primer for oncology. Photodiagnosis and Photodynamic Therapy 2016;13:73-80. [DOI: 10.1016/j.pdpdt.2015.11.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
220 Wada Y, Takami Y, Tateishi M, Ryu T, Mikagi K, Saitsu H. Efficacy of surgical treatment using microwave coagulo-necrotic therapy for unresectable multiple colorectal liver metastases. Onco Targets Ther 2016;9:937-43. [PMID: 26955286 DOI: 10.2147/OTT.S97824] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
221 Zech CJ, Justo N, Lang A, Ba-Ssalamah A, Kim MJ, Rinde H, Jonas E. Cost evaluation of gadoxetic acid-enhanced magnetic resonance imaging in the diagnosis of colorectal-cancer metastasis in the liver: Results from the VALUE Trial. Eur Radiol 2016;26:4121-30. [PMID: 26905871 DOI: 10.1007/s00330-016-4271-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 3.7] [Reference Citation Analysis]
222 Frilling A, Ebert M. Treatment of Non-Colorectal Liver Metastases. Viszeralmedizin 2015;31:386. [PMID: 26889140 DOI: 10.1159/000442900] [Reference Citation Analysis]
223 Vilgrain V, Esvan M, Ronot M, Caumont-Prim A, Aubé C, Chatellier G. A meta-analysis of diffusion-weighted and gadoxetic acid-enhanced MR imaging for the detection of liver metastases. Eur Radiol 2016;26:4595-615. [PMID: 26883327 DOI: 10.1007/s00330-016-4250-5] [Cited by in Crossref: 78] [Cited by in F6Publishing: 73] [Article Influence: 13.0] [Reference Citation Analysis]
224 Hosseini-Nik H, Fischer SE, Moulton CA, Karbhase G, Menezes RJ, Gallinger S, Jhaveri KS. Diffusion-weighted and hepatobiliary phase gadoxetic acid-enhanced quantitative MR imaging for identification of complete pathologic response in colorectal liver metastases after preoperative chemotherapy. Abdom Radiol (NY) 2016;41:231-8. [PMID: 26867904 DOI: 10.1007/s00261-015-0572-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
225 Hosokawa I, Allard M, Gelli M, Ciacio O, Vibert E, Cherqui D, Sa Cunha A, Castaing D, Miyazaki M, Adam R. Long-Term Survival Benefit and Potential for Cure after R1 Resection for Colorectal Liver Metastases. Ann Surg Oncol 2016;23:1897-905. [DOI: 10.1245/s10434-015-5060-8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
226 Coelho FF, Kruger JAP, Fonseca GM, Araújo RLC, Jeismann VB, Perini MV, Lupinacci RM, Cecconello I, Herman P. Laparoscopic liver resection: Experience based guidelines. World J Gastrointest Surg 2016; 8(1): 5-26 [PMID: 26843910 DOI: 10.4240/wjgs.v8.i1.5] [Cited by in CrossRef: 61] [Cited by in F6Publishing: 59] [Article Influence: 10.2] [Reference Citation Analysis]
227 Imai K, Allard MA, Castro Benitez C, Vibert E, Sa Cunha A, Cherqui D, Castaing D, Bismuth H, Baba H, Adam R. Nomogram for prediction of prognosis in patients with initially unresectable colorectal liver metastases. Br J Surg 2016;103:590-9. [PMID: 26780341 DOI: 10.1002/bjs.10073] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
228 Hau HM, Tautenhahn H-, Schmelzle M, Morgul HM, Moche M, Bartels M, Uhlmann D. Current strategies for preoperative conditioning of the liver to expand criteria for resectability of hepatic metastases. Eur Surg 2016;48:180-90. [DOI: 10.1007/s10353-015-0381-1] [Reference Citation Analysis]
229 Zhang T, Fu J, Li Y, Wang Y, Zhang L, Liu Y. Bone morphogenetic protein 7 is associated with the nodal invasion of colon cancer. Oncol Lett 2016;11:1707-12. [PMID: 26998065 DOI: 10.3892/ol.2016.4102] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
230 Bhutiani N, Philips P, Martin RC 2nd, Scoggins CR. Impact of surgical margin clearance for resection of secondary hepatic malignancies. J Surg Oncol. 2016;113:289-295. [PMID: 26662026 DOI: 10.1002/jso.24107] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
231 Jones RP, Poston GJ. Decision Making Around Optimal Management of Liver-Limited Metastatic Colorectal Cancer. Ann Surg Oncol 2016;23:353-4. [PMID: 26631387 DOI: 10.1245/s10434-015-5002-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
232 Llado L, Muñoz A, Ramos E, Torras J, Fabregat J, Rafecas A. The anterior hanging-approach improves postoperative course after right hepatectomy in patients with colorectal liver metastases. Results of a prospective study with propensity-score matching comparison. Eur J Surg Oncol 2016;42:176-83. [PMID: 26710993 DOI: 10.1016/j.ejso.2015.11.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
233 Lévi FA, Boige V, Hebbar M, Smith D, Lepère C, Focan C, Karaboué A, Guimbaud R, Carvalho C, Tumolo S, Innominato P, Ajavon Y, Truant S, Castaing D, De Baere T, Kunstlinger F, Bouchahda M, Afshar M, Rougier P, Adam R, Ducreux M; Association Internationale pour Recherche sur Temps Biologique et Chronothérapie (ARTBC International). Conversion to resection of liver metastases from colorectal cancer with hepatic artery infusion of combined chemotherapy and systemic cetuximab in multicenter trial OPTILIV. Ann Oncol 2016;27:267-74. [PMID: 26578731 DOI: 10.1093/annonc/mdv548] [Cited by in Crossref: 56] [Cited by in F6Publishing: 54] [Article Influence: 8.0] [Reference Citation Analysis]
234 Choti MA, Thomas M, Wong SL, Eaddy M, Pawlik TM, Hirose K, Weiss MJ, Kish J, Green MR. Surgical Resection Preferences and Perceptions among Medical Oncologists Treating Liver Metastases from Colorectal Cancer. Ann Surg Oncol. 2016;23:375-381. [PMID: 26561404 DOI: 10.1245/s10434-015-4925-1] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 3.9] [Reference Citation Analysis]
235 Khokhlova TD, Haider Y, Hwang JH. Therapeutic potential of ultrasound microbubbles in gastrointestinal oncology: recent advances and future prospects. Therap Adv Gastroenterol 2015;8:384-94. [PMID: 26557894 DOI: 10.1177/1756283X15592584] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
236 Tirumani SH, Kim KW, Nishino M, Howard SA, Krajewski KM, Jagannathan JP, Cleary JM, Ramaiya NH, Shinagare AB. Update on the role of imaging in management of metastatic colorectal cancer. Radiographics. 2014;34:1908-1928. [PMID: 25384292 DOI: 10.1148/rg.347130090] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 7.0] [Reference Citation Analysis]
237 Muangkaew P, Cho JY, Han HS, Yoon YS, Choi Y, Jang JY, Choi H, Jang JS, Kwon SU. Outcomes of Simultaneous Major Liver Resection and Colorectal Surgery for Colorectal Liver Metastases. J Gastrointest Surg. 2016;20:554-563. [PMID: 26471363 DOI: 10.1007/s11605-015-2979-9] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.7] [Reference Citation Analysis]
238 Matos AP, Altun E, Ramalho M, Velloni F, Alobaidy M, Semelka RC. An overview of imaging techniques for liver metastases management. Expert Review of Gastroenterology & Hepatology 2015;9:1561-76. [DOI: 10.1586/17474124.2015.1092873] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
239 Ali MA, Di Sandro S, Lauterio A, Concone G, Mangoni I, Ferla F, Rotiroti V, Cusumano C, Giacomoni A, De Carlis L. Repeat Hepatectomy for Recurrent Colorectal Liver Metastases: Is it Worth the Challenge? J Gastrointest Surg. 2015;19:2192-2198. [PMID: 26361773 DOI: 10.1007/s11605-015-2939-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
240 Zaydfudim VM, McMurry TL, Harrigan AM, Friel CM, Stukenborg GJ, Bauer TW, Adams RB, Hedrick TL. Improving treatment and survival: a population-based study of current outcomes after a hepatic resection in patients with metastatic colorectal cancer. HPB (Oxford) 2015;17:1019-24. [PMID: 26353888 DOI: 10.1111/hpb.12488] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
241 Bajpai S, Kambadakone A, Guimaraes AR, Arellano RS, Gervais DA, Sahani D. Image-guided Treatment in the Hepatobiliary System: Role of Imaging in Treatment Planning and Posttreatment Evaluation. RadioGraphics 2015;35:1393-418. [DOI: 10.1148/rg.2015140281] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
242 Yalcin S, Trad D, Kader YA, Halawani H, Demir OG, Mall R, Meshcheryakov A, Nasr F, Nosworthy A, Osinsky D. Personalized treatment is better than one treatment fits all in the management of patients with mCRC: a consensus statement. Future Oncol. 2014;10:2643-2657. [PMID: 25531050 DOI: 10.2217/fon.14.203] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
243 Lordick F, Ricke J, Mohnike K, Hacker U. How to Create Evidence for the Integration of Local and Locoregional Treatments in Future Oncological Treatment Concepts? Viszeralmedizin 2014;30:261-8. [PMID: 26288599 DOI: 10.1159/000365313] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
244 Benckert C, Bruns C. The Surgeon's Contribution to Image-Guided Oncology. Viszeralmedizin 2014;30:232-6. [PMID: 26288021 DOI: 10.1159/000366458] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
245 Qadan M, D'Angelica MI. Complex Surgical Strategies to Improve Resectability in Borderline-Resectable Disease. Curr Colorectal Cancer Rep. 2015;11:369-377. [PMID: 28090195 DOI: 10.1007/s11888-015-0290-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
246 Tranchart H, Fuks D, Vigano L, Ferretti S, Paye F, Wakabayashi G, Ferrero A, Gayet B, Dagher I. Laparoscopic simultaneous resection of colorectal primary tumor and liver metastases: a propensity score matching analysis. Surg Endosc. 2016;30:1853-1862. [PMID: 26275554 DOI: 10.1007/s00464-016-4766-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
247 Tranchart H, Fuks D, Vigano L, Ferretti S, Paye F, Wakabayashi G, Ferrero A, Gayet B, Dagher I. Laparoscopic simultaneous resection of colorectal primary tumor and liver metastases: a propensity score matching analysis. Surg Endosc. 2016;30:1853-1862. [PMID: 26275554 DOI: 10.1007/s00464-015-4467-4] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 4.3] [Reference Citation Analysis]
248 Bazarbashi S, Aljubran A, Alzahrani A, Mohieldin A, Soudy H, Shoukri M. Phase I/II trial of capecitabine, oxaliplatin, and irinotecan in combination with bevacizumab in first line treatment of metastatic colorectal cancer. Cancer Med 2015;4:1505-13. [PMID: 26207614 DOI: 10.1002/cam4.497] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
249 Liu W, Sun Y, Zhang L, Xing BC. Negative surgical margin improved long-term survival of colorectal cancer liver metastases after hepatic resection: a systematic review and meta-analysis. Int J Colorectal Dis. 2015;30:1365-1373. [PMID: 26198997 DOI: 10.1007/s00384-015-2323-6] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
250 Vassos N, Agaimy A, Hohenberger W, Croner RS. Management of liver metastases of gastrointestinal stromal tumors (GIST). Annals of Hepatology 2015;14:531-9. [DOI: 10.1016/s1665-2681(19)31175-5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
251 Adam R, de Gramont A, Figueras J, Kokudo N, Kunstlinger F, Loyer E, Poston G, Rougier P, Rubbia-Brandt L, Sobrero A, Teh C, Tejpar S, Van Cutsem E, Vauthey JN, Påhlman L; of the EGOSLIM (Expert Group on OncoSurgery management of LIver Metastases) group. Managing synchronous liver metastases from colorectal cancer: a multidisciplinary international consensus. Cancer Treat Rev 2015;41:729-41. [PMID: 26417845 DOI: 10.1016/j.ctrv.2015.06.006] [Cited by in Crossref: 257] [Cited by in F6Publishing: 251] [Article Influence: 36.7] [Reference Citation Analysis]
252 Parvizi N, Franklin JM, McGowan DR, Teoh EJ, Bradley KM, Gleeson FV. Does a novel penalized likelihood reconstruction of 18F-FDG PET-CT improve signal-to-background in colorectal liver metastases? Eur J Radiol. 2015;84:1873-1878. [PMID: 26163992 DOI: 10.1016/j.ejrad.2015.06.025] [Cited by in Crossref: 53] [Cited by in F6Publishing: 56] [Article Influence: 7.6] [Reference Citation Analysis]
253 Chan DL, Alzahrani NA, Morris DL, Chua TC. Systematic review and meta-analysis of hepatic arterial infusion chemotherapy as bridging therapy for colorectal liver metastases. Surg Oncol. 2015;24:162-171. [PMID: 26133575 DOI: 10.1016/j.suronc.2015.06.014] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
254 Waisberg J, Ivankovics IG. Liver-first approach of colorectal cancer with synchronous hepatic metastases: A reverse strategy. World J Hepatol 2015; 7(11): 1444-1449 [PMID: 26085905 DOI: 10.4254/wjh.v7.i11.1444] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
255 Ihnát P, Vávra P, Zonča P. Treatment strategies for colorectal carcinoma with synchronous liver metastases: Which way to go? World J Gastroenterol 2015; 21(22): 7014-7021 [PMID: 26078580 DOI: 10.3748/wjg.v21.i22.7014] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 26] [Article Influence: 4.1] [Reference Citation Analysis]
256 Yang C, Rahbari NN, Mees ST, Schaab F, Koch M, Weitz J, Reissfelder C. Staged resection of bilobar colorectal liver metastases: surgical strategies. Langenbecks Arch Surg. 2015;400:633-640. [PMID: 26049744 DOI: 10.1007/s00423-015-1310-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.9] [Reference Citation Analysis]
257 Liu W, Song Q, Xing B. A systematic review and meta-analysis to reappraise the role of adjuvant hepatic arterial infusion for colorectal cancer liver metastases. Int J Colorectal Dis 2015;30:1091-102. [DOI: 10.1007/s00384-015-2246-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
258 Beppu T, Wakabayashi G, Hasegawa K, Gotohda N, Mizuguchi T, Takahashi Y, Hirokawa F, Taniai N, Watanabe M, Katou M, Nagano H, Honda G, Baba H, Kokudo N, Konishi M, Hirata K, Yamamoto M, Uchiyama K, Uchida E, Kusachi S, Kubota K, Mori M, Takahashi K, Kikuchi K, Miyata H, Takahara T, Nakamura M, Kaneko H, Yamaue H, Miyazaki M, Takada T. Long-term and perioperative outcomes of laparoscopic vs open liver resection for colorectal liver metastases with propensity score matching: a multi-institutional Japanese study. J Hepatobiliary Pancreat Sci. 2015;22:711-720. [PMID: 25902703 DOI: 10.1002/jhbp.261] [Cited by in Crossref: 105] [Cited by in F6Publishing: 89] [Article Influence: 15.0] [Reference Citation Analysis]
259 Seeberg LT, Waage A, Brunborg C, Hugenschmidt H, Renolen A, Stav I, Bjørnbeth BA, Brudvik KW, Borgen EF, Naume B, Wiedswang G. Circulating tumor cells in patients with colorectal liver metastasis predict impaired survival. Ann Surg 2015;261:164-71. [PMID: 24509211 DOI: 10.1097/SLA.0000000000000580] [Cited by in Crossref: 35] [Cited by in F6Publishing: 39] [Article Influence: 5.0] [Reference Citation Analysis]
260 Brudvik KW, Seeberg LT, Hugenschmidt H, Renolen A, Schirmer CB, Brunborg C, Bjørnbeth BA, Borgen E, Naume B, Waage A, Wiedswang G. Detection of Circulating Tumor Cells at Surgery and at Follow-Up Assessment to Predict Survival After Two-Stage Liver Resection of Colorectal Liver Metastases. Ann Surg Oncol 2015;22:4029-37. [DOI: 10.1245/s10434-015-4482-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
261 Navarro-Freire F, Navarro-Sánchez P, García-Agua N, Pérez-Cabrera B, Palomeque-Jiménez A, Jiménez-Rios JA, García-López PA, García-Ruiz AJ. Effectiveness of surgery in liver metastasis from colorectal cancer: experience and results of a continuous improvement process. Clin Transl Oncol 2015;17:547-56. [PMID: 25775916 DOI: 10.1007/s12094-015-1277-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
262 Han K, Park SH, Kim KW, Kim HJ, Lee SS, Kim JC, Yu CS, Lim S, Joo Y, Kim AY, Ha HK. Use of Liver Magnetic Resonance Imaging After Standard Staging Abdominopelvic Computed Tomography to Evaluate Newly Diagnosed Colorectal Cancer Patients. Annals of Surgery 2015;261:480-6. [DOI: 10.1097/sla.0000000000000708] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
263 Beppu T, Sakamoto Y, Hayashi H, Baba H. Perioperative chemotherapy and hepatic resection for resectable colorectal liver metastases. Hepatobiliary Surg Nutr 2015;4:72-5. [PMID: 25713806 DOI: 10.3978/j.issn.2304-3881.2014.07.08] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
264 Viganò L, Capussotti L, Majno P, Toso C, Ferrero A, De Rosa G, Rubbia-Brandt L, Mentha G. Liver resection in patients with eight or more colorectal liver metastases. Br J Surg 2015;102:92-101. [PMID: 25451181 DOI: 10.1002/bjs.9680] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 5.3] [Reference Citation Analysis]
265 Araujo RL, Gönen M, Herman P. Chemotherapy for patients with colorectal liver metastases who underwent curative resection improves long-term outcomes: systematic review and meta-analysis. Ann Surg Oncol 2015;22:3070-8. [PMID: 25586244 DOI: 10.1245/s10434-014-4354-6] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 4.6] [Reference Citation Analysis]
266 Kümler I, Parner VK, Tuxen MK, Skjoldbye B, Bergenfeldt M, Nelausen KM, Nielsen DL. Clinical outcome of percutaneous RF-ablation of non-operable patients with liver metastasis from breast cancer. Radiol med 2015;120:536-41. [DOI: 10.1007/s11547-014-0489-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
267 Skipenko OG, Bedzhanyan AL, Polishchuk LO. The role of prognostic models in metastatic colorectal liver cancer surgery. Khirurgiia (Mosk) 2015;:56-71. [PMID: 26978765 DOI: 10.17116/hirurgia20151256-71] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
268 Gruenberger T, Bridgewater J, Chau I, García Alfonso P, Rivoire M, Mudan S, Lasserre S, Hermann F, Waterkamp D, Adam R. Bevacizumab plus mFOLFOX-6 or FOLFOXIRI in patients with initially unresectable liver metastases from colorectal cancer: the OLIVIA multinational randomised phase II trial. Ann Oncol. 2015;26:702-708. [PMID: 25538173 DOI: 10.1093/annonc/mdu580] [Cited by in Crossref: 154] [Cited by in F6Publishing: 170] [Article Influence: 19.3] [Reference Citation Analysis]
269 Margonis GA, Spolverato G, Kim Y, Ejaz A, Pawlik TM. Intraoperative surgical margin re-resection for colorectal liver metastasis: is it worth the effort? J Gastrointest Surg. 2015;19:699-707. [PMID: 25451734 DOI: 10.1007/s11605-014-2710-2] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
270 Kubota Y, Otsuka Y, Tsuchiya M, Katagiri T, Ishii J, Maeda T, Tamura A, Kaneko H. Efficacy of laparoscopic liver resection in colorectal liver metastases and the influence of preoperative chemotherapy. World J Surg Oncol 2014;12:351. [PMID: 25416585 DOI: 10.1186/1477-7819-12-351] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
271 Cucchetti A, Ferrero A, Cescon M, Donadon M, Russolillo N, Ercolani G, Stacchini G, Mazzotti F, Torzilli G, Pinna AD. Cure Model Survival Analysis After Hepatic Resection for Colorectal Liver Metastases. Ann Surg Oncol 2015;22:1908-14. [DOI: 10.1245/s10434-014-4234-0] [Cited by in Crossref: 42] [Cited by in F6Publishing: 48] [Article Influence: 5.3] [Reference Citation Analysis]
272 Patrlj L, Kopljar M, Kliček R, Patrlj MH, Kolovrat M, Rakić M, Duzel A. The surgical treatment of patients with colorectal cancer and liver metastases in the setting of the "liver first" approach. Hepatobiliary Surg Nutr 2014;3:324-9. [PMID: 25392845 DOI: 10.3978/j.issn.2304-3881.2014.09.12] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
273 Li L, Ma BB. Colorectal cancer in Chinese patients: current and emerging treatment options. Onco Targets Ther. 2014;7:1817-1828. [PMID: 25336973 DOI: 10.2147/OTT.S48409ott-7-1817] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
274 Li L, Ma BB. Colorectal cancer in Chinese patients: current and emerging treatment options. Onco Targets Ther. 2014;7:1817-1828. [PMID: 25336973 DOI: 10.2147/OTT.S48409] [Cited by in Crossref: 3] [Cited by in F6Publishing: 23] [Article Influence: 0.4] [Reference Citation Analysis]
275 Nigri G, Petrucciani N, Ferla F, La Torre M, Aurello P, Ramacciato G. Neoadjuvant chemotherapy for resectable colorectal liver metastases: what is the evidence? Results of a systematic review of comparative studies. Surgeon. 2015;13:83-90. [PMID: 25257725 DOI: 10.1016/j.surge.2014.07.005] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
276 Scorsetti M, Comito T, Tozzi A, Navarria P, Fogliata A, Clerici E, Mancosu P, Reggiori G, Rimassa L, Torzilli G, Tomatis S, Santoro A, Cozzi L. Final results of a phase II trial for stereotactic body radiation therapy for patients with inoperable liver metastases from colorectal cancer. J Cancer Res Clin Oncol 2015;141:543-53. [PMID: 25245052 DOI: 10.1007/s00432-014-1833-x] [Cited by in Crossref: 78] [Cited by in F6Publishing: 81] [Article Influence: 9.8] [Reference Citation Analysis]
277 Van Cutsem E, Cervantes A, Nordlinger B, Arnold D; ESMO Guidelines Working Group. Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2014;25 Suppl 3:iii1-iii9. [PMID: 25190710 DOI: 10.1093/annonc/mdu260] [Cited by in Crossref: 559] [Cited by in F6Publishing: 627] [Article Influence: 69.9] [Reference Citation Analysis]
278 Cheng A, Li J, Vaid AK, Ma BBY, Teh C, Ahn JB, Bello M, Charoentum C, Chen L, de Lima Lopes G, Ho GF, Kong HL, Lam KO, Liu TS, Park YS, Sriuranpong V, Sudoyo AW, Wang J, Zhang J, Zhang SZ, Ciardiello F, Köhne C, Shaw M, Kim TW. Adaptation of International Guidelines for Metastatic Colorectal Cancer: An Asian Consensus. Clinical Colorectal Cancer 2014;13:145-55. [DOI: 10.1016/j.clcc.2014.06.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
279 Kolev V, Pereira EB, Schwartz M, Sarpel U, Roayaie S, Labow D, Momeni M, Chuang L, Dottino P, Rahaman J. The role of liver resection at the time of secondary cytoreduction in patients with recurrent ovarian cancer. Int J Gynecol Cancer. 2014;24:70-74. [PMID: 24356412 DOI: 10.1097/igc.0000000000000026] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
280 Costi R, Leonardi F, Zanoni D, Violi V, Roncoroni L. Palliative care and end-stage colorectal cancer management: The surgeon meets the oncologist. World J Gastroenterol 2014; 20(24): 7602-7621 [PMID: 24976699 DOI: 10.3748/wjg.v20.i24.7602] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 30] [Article Influence: 4.5] [Reference Citation Analysis]
281 Uppal A, Ferguson MK, Posner MC, Hellman S, Khodarev NN, Weichselbaum RR. Towards a molecular basis of oligometastatic disease: potential role of micro-RNAs. Clin Exp Metastasis. 2014;31:735-748. [PMID: 24968866 DOI: 10.1007/s10585-014-9664-3] [Cited by in Crossref: 48] [Cited by in F6Publishing: 52] [Article Influence: 6.0] [Reference Citation Analysis]
282 Saiura A, Yamamoto J, Koga R, Takahashi Y, Takahashi M, Inoue Y, Ono Y, Kokudo N. Favorable Outcome After Repeat Resection for Colorectal Liver Metastases. Ann Surg Oncol 2014;21:4293-9. [DOI: 10.1245/s10434-014-3863-7] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 4.5] [Reference Citation Analysis]
283 Marino D, Leone F, D'Avanzo F, Ribero D, Capussotti L, Aglietta M. Potentially resectable metastatic colorectal cancer: an individualized approach to conversion therapy. Crit Rev Oncol Hematol 2014;92:218-26. [PMID: 24985058 DOI: 10.1016/j.critrevonc.2014.05.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
284 Siriwardena AK, Mason JM, Mullamitha S, Hancock HC, Jegatheeswaran S. Management of colorectal cancer presenting with synchronous liver metastases. Nat Rev Clin Oncol 2014;11:446-59. [DOI: 10.1038/nrclinonc.2014.90] [Cited by in Crossref: 75] [Cited by in F6Publishing: 82] [Article Influence: 9.4] [Reference Citation Analysis]
285 Jones RP, Hamann S, Malik HZ, Fenwick SW, Poston GJ, Folprecht G. Defined criteria for resectability improves rates of secondary resection after systemic therapy for liver limited metastatic colorectal cancer. European Journal of Cancer 2014;50:1590-601. [DOI: 10.1016/j.ejca.2014.02.024] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 4.8] [Reference Citation Analysis]
286 Jones R, Stättner S, Sutton P, Dunne D, Mcwhirter D, Fenwick S, Malik H, Poston G. Controversies in the oncosurgical management of liver limited stage IV colorectal cancer. Surgical Oncology 2014;23:53-60. [DOI: 10.1016/j.suronc.2014.02.002] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 4.0] [Reference Citation Analysis]
287 Aloia TA, Zimmitti G, Conrad C, Gottumukalla V, Kopetz S, Vauthey JN. Return to intended oncologic treatment (RIOT): a novel metric for evaluating the quality of oncosurgical therapy for malignancy. J Surg Oncol 2014;110:107-14. [PMID: 24846705 DOI: 10.1002/jso.23626] [Cited by in Crossref: 120] [Cited by in F6Publishing: 113] [Article Influence: 15.0] [Reference Citation Analysis]
288 Engstrand J, Nilsson H, Jansson A, Isaksson B, Freedman J, Lundell L, Jonas E. A multiple microwave ablation strategy in patients with initially unresectable colorectal cancer liver metastases - A safety and feasibility study of a new concept. Eur J Surg Oncol. 2014;40:1488-1493. [PMID: 24933395 DOI: 10.1016/j.ejso.2014.05.003] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
289 Scilletta R, Pagano D, Spada M, Mongiovì S, Pesce A, Portale TR, Guardabasso V, Puleo S, Gruttadauria S. Comparative analysis of the incidence of surgical site infections in patients with liver resection for colorectal hepatic metastases after neoadjuvant chemotherapy. J Surg Res 2014;188:183-9. [PMID: 24398304 DOI: 10.1016/j.jss.2013.11.1092] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
290 Cervantes A. Exploring better strategies for EGFR antibodies in colon cancer. The Lancet Oncology 2014;15:549-50. [DOI: 10.1016/s1470-2045(14)70137-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
291 Vitale FV, Romeo P, Luciani B, Raffaele M, Colina P, Ferraù F. Mitomycin-based hepatic arterial infusion chemotherapy for solitary ampullary cancer liver metastasis: an unusual treatment for an uncommon disease. J Oncol Pharm Pract 2015;21:396-9. [DOI: 10.1177/1078155214531512] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
292 Gómez-dorronsoro M, Miquel R, Ortega L, Hörndler C, Antúnez JR, Villar-pastor CM, Vera R, Plaza C, García M, Díaz E, Ortiz RM, Pérez J, Pereira S, López-rios F, González-cámpora R. Recomendaciones para el estudio patológico de las metástasis hepáticas de cáncer colorrectal tras neoadyuvancia. Consenso Nacional de la Sociedad Española de Anatomía Patológica. Revista Española de Patología 2014;47:90-8. [DOI: 10.1016/j.patol.2014.01.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
293 Zech CJ, Korpraphong P, Huppertz A, Denecke T, Kim MJ, Tanomkiat W, Jonas E, Ba-Ssalamah A; VALUE study group. Randomized multicentre trial of gadoxetic acid-enhanced MRI versus conventional MRI or CT in the staging of colorectal cancer liver metastases. Br J Surg. 2014;101:613-621. [PMID: 24652690 DOI: 10.1002/bjs.9465] [Cited by in Crossref: 82] [Cited by in F6Publishing: 79] [Article Influence: 10.3] [Reference Citation Analysis]
294 Oba M, Hasegawa K, Matsuyama Y, Shindoh J, Mise Y, Aoki T, Sakamoto Y, Sugawara Y, Makuuchi M, Kokudo N. Discrepancy Between Recurrence-Free Survival and Overall Survival in Patients with Resectable Colorectal Liver Metastases: A Potential Surrogate Endpoint for Time to Surgical Failure. Ann Surg Oncol 2014;21:1817-24. [DOI: 10.1245/s10434-014-3504-1] [Cited by in Crossref: 45] [Cited by in F6Publishing: 50] [Article Influence: 5.6] [Reference Citation Analysis]
295 Bonanni L, De’liguori Carino N, Deshpande R, Ammori BJ, Sherlock DJ, Valle JW, Tam E, O’Reilly DA. A comparison of diagnostic imaging modalities for colorectal liver metastases. Eur J Surg Oncol. 2014;40:545-550. [PMID: 24491289 DOI: 10.1016/j.ejso.2013.12.023] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 3.6] [Reference Citation Analysis]
296 Viganò L, Capussotti L, Lapointe R, Barroso E, Hubert C, Giuliante F, Ijzermans JN, Mirza DF, Elias D, Adam R. Early recurrence after liver resection for colorectal metastases: risk factors, prognosis, and treatment. A LiverMetSurvey-based study of 6,025 patients. Ann Surg Oncol. 2014;21:1276-1286. [PMID: 24346766 DOI: 10.1245/s10434-013-3421-8] [Cited by in Crossref: 108] [Cited by in F6Publishing: 121] [Article Influence: 12.0] [Reference Citation Analysis]
297 Németh Z, Boér K, Kásler M, Borbély K. [Clinical use of 18F-FDG PET/CT in colorectal carcinoma]. Orv Hetil 2013;154:1447-53. [PMID: 24016751 DOI: 10.1556/OH.2013.29700] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
298 Viganò L, Capussotti L, De Rosa G, De Saussure WO, Mentha G, Rubbia-brandt L. Liver Resection for Colorectal Metastases after Chemotherapy: Impact of Chemotherapy-Related Liver Injuries, Pathological Tumor Response, and Micrometastases on Long-term Survival. Annals of Surgery 2013;258:731-42. [DOI: 10.1097/sla.0b013e3182a6183e] [Cited by in Crossref: 117] [Cited by in F6Publishing: 115] [Article Influence: 13.0] [Reference Citation Analysis]
299 Vibert E, Pittau G, Gelli M, Cunha AS, Jamot L, Faivre J, Castro Benitez C, Castaing D, Adam R. Actual incidence and long-term consequences of posthepatectomy liver failure after hepatectomy for colorectal liver metastases. Surgery. 2014;155:94-105. [PMID: 24694360 DOI: 10.1016/j.surg.2013.05.039] [Cited by in Crossref: 25] [Cited by in F6Publishing: 30] [Article Influence: 2.8] [Reference Citation Analysis]
300 Tabernero J, Van Cutsem E, Lakomý R, Prausová J, Ruff P, van Hazel GA, Moiseyenko VM, Ferry DR, McKendrick JJ, Soussan-Lazard K. Aflibercept versus placebo in combination with fluorouracil, leucovorin and irinotecan in the treatment of previously treated metastatic colorectal cancer: prespecified subgroup analyses from the VELOUR trial. Eur J Cancer. 2014;50:320-331. [PMID: 24140268 DOI: 10.1016/j.ejca.2013.09.013] [Cited by in Crossref: 142] [Cited by in F6Publishing: 129] [Article Influence: 15.8] [Reference Citation Analysis]
301 Haraldsdottir S, Wu C, Bloomston M, Goldberg RM. What is the optimal neo-adjuvant treatment for liver metastasis? Ther Adv Med Oncol. 2013;5:221-234. [PMID: 23858331 DOI: 10.1177/1758834013485111] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
302 Schulz A. Response to "contrast-enhanced intraoperative ultrasound". Acta Radiol 2013;54:533. [PMID: 24879880 DOI: 10.1177/0284185113485679] [Reference Citation Analysis]
303 Meriggi F, Bertocchi P, Zaniboni A. Management of potentially resectable colorectal cancer liver metastases. World J Gastrointest Surg 2013; 5(5): 138-145 [PMID: 23710291 DOI: 10.4240/wjgs.v5.i5.138] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
304 Farid SG, Prasad KR, Morris-Stiff G. Operative terminology and post-operative management approaches applied to hepatic surgery: Trainee perspectives. World J Gastrointest Surg 2013; 5(5): 146-155 [PMID: 23710292 DOI: 10.4240/wjgs.v5.i5.146] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
305 Voorthuizen TV, van Gulik TM, Punt CJ. Defining resectability of colorectal liver metastases: how and why? Colorectal Cancer 2013;2:61-72. [DOI: 10.2217/crc.12.79] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]